drug1	drug2	strength	RR	severity	patients.fem.mal	description	color	onethousand	fdr
Digoxin	Furosemide	0.306	1.384	Moderate	9663 (7301/2362)	The risk or severity of adverse effects can be increased when Furosemide is combined with Digoxin.	#F6B6B6	4392.37255392168	1.08969724435335e-283
Acetaminophen	Acenocoumarol	0.282	-1.073	None	13547 (9150/4397)	Acetaminophen may increase the anticoagulant activities of Acenocoumarol.	#B4D1E6	6157.8672242551	1
Omeprazole	Alprazolam	0.329	1.909	Moderate	8969 (7265/1704)	The metabolism of Alprazolam can be decreased when combined with Omeprazole.	#F1ABAB	4076.9108388827	1
Acetylsalicylic acid	Ibuprofen	0.129	1.121	Major	9944 (7107/2837)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Ibuprofen.	#F8BABA	4520.10272960749	1
Omeprazole	Diazepam	0.198	1.635	Moderate	5717 (4488/1229)	The metabolism of Diazepam can be decreased when combined with Omeprazole.	#F4B1B1	2598.69542489602	1
Prednisone	Acetylsalicylic acid	0.149	-1.2	Moderate	6944 (4517/2427)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Prednisone.	#B1CFE5	3156.43537353122	1
Furosemide	Ibuprofen	0.157	1.281	Moderate	7145 (5295/1850)	The therapeutic efficacy of Furosemide can be decreased when used in combination with Ibuprofen.	#F7B7B7	3247.80108638833	1
Digoxin	Spironolactone	0.334	1.386	Minor	1847 (1396/451)	The serum concentration of Digoxin can be increased when it is combined with Spironolactone.	#F6B6B6	839.564535557626	5.52028801805659e-131
Rivastigmine	Quetiapine	0.331	1.067	Moderate	1086 (765/321)		#F9BCBC	493.647582899611	1.3856563462039e-160
Acetylsalicylic acid	Gliclazide	0.38	-1.167	None	2593 (1703/890)	Acetylsalicylic acid may increase the hypoglycemic activities of Gliclazide.	#B1CFE5	1178.66315143526	1
Omeprazole	Clonazepam	0.256	1.458	Moderate	2175 (1664/511)		#F5B4B4	988.658833155299	1
Amiodarone	Acenocoumarol	0.324	-1.315	None	1274 (802/472)	The therapeutic efficacy of Acenocoumarol can be increased when used in combination with Amiodarone.	#AFCEE4	579.104070547058	1.90262240494201e-49
Allopurinol	Acenocoumarol	0.314	-2.635	None	2247 (1031/1216)	Allopurinol may increase the anticoagulant activities of Acenocoumarol.	#96BBD9	1021.38684970113	6.56542884568818e-19
Spironolactone	Enalapril	0.306	1.015	Major	2470 (1714/756)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Enalapril.	#F9BCBC	1122.75278983613	1
Donepezil	Quetiapine	0.372	1.027	Moderate	962 (670/292)		#F9BCBC	437.282665515125	1.2846321966531e-68
Trazodone	Donepezil	0.323	1.341	Moderate	775 (581/194)		#F6B6B6	352.280733653038	2.98569350133059e-55
Levothyroxine	Acenocoumarol	0.3	1.649	None	1419 (1116/303)	Levothyroxine may increase the anticoagulant activities of Acenocoumarol.	#F3AFAF	645.014659424078	1
Acetylsalicylic acid	Methylprednisolone	0.137	1.135	Moderate	1898 (1361/537)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Methylprednisolone.	#F8BABA	862.746880610923	1
Acetylsalicylic acid	Glyburide	0.327	-1.092	Moderate	1386 (931/455)	Acetylsalicylic acid may increase the hypoglycemic activities of Glyburide.	#B2D0E5	630.014318507239	1
Risperidone	Donepezil	0.295	1.316	Moderate	796 (594/202)		#F7B7B7	361.826405145571	9.87907457812385e-34
Trazodone	Rivastigmine	0.293	-1.014	Moderate	695 (478/217)		#B4D1E6	315.916270824337	4.72971536284074e-57
Torasemide	Ibuprofen	0.162	1.381	Moderate	2006 (1515/491)	The therapeutic efficacy of Torasemide can be decreased when used in combination with Ibuprofen.	#F6B6B6	911.838905429669	1
Digoxin	Levothyroxine	0.313	2.3	Moderate	1019 (853/166)		#EDA3A3	463.192345280575	1
Alendronic acid	Ibuprofen	0.185	4.148	Moderate	1160 (1047/113)	The risk or severity of adverse effects can be increased when Ibuprofen is combined with Alendronic acid.	#DD7E7E	527.284711016159	1
Digoxin	Carvedilol	0.295	1.172	Moderate	738 (534/204)	Digoxin may increase the bradycardic activities of Carvedilol.	#F7B9B9	335.462169594764	0.000196851676857327
Citalopram	Acenocoumarol	0.337	1.197	None	1381 (1005/376)	The metabolism of Acenocoumarol can be decreased when combined with Citalopram.	#F7B9B9	627.741539580445	1
Bisoprolol	Salbutamol	0.18	-1.098	Moderate	1824 (1223/601)	Bisoprolol may decrease the bronchodilatory activities of Salbutamol.	#B2D0E5	829.109752494375	1
Digoxin	Alprazolam	0.252	2.07	Moderate	1001 (823/178)		#F0A7A7	455.010341144117	1
Digoxin	Hydrochlorothiazide	0.285	1.813	Moderate	1520 (1219/301)	The risk or severity of adverse effects can be increased when Hydrochlorothiazide is combined with Digoxin.	#F2ACAC	690.924793745312	1
Prednisone	Acenocoumarol	0.172	-1.46	None	1809 (1094/715)		#ACCCE3	822.291415713994	1
Galantamine	Quetiapine	0.372	1.043	Moderate	463 (324/139)	Galantamine may increase the QTc-prolonging activities of Quetiapine.	#F9BCBC	210.459328621105	2.35961678389424e-38
Acetylsalicylic acid	Insulin detemir	0.335	1.11	Moderate	849 (605/244)	Acetylsalicylic acid may increase the hypoglycemic activities of Insulin Detemir.	#F8BABA	385.917861769586	1
Tramadol	Citalopram	0.252	2.201	Major	1343 (1116/227)	Citalopram may increase the neuroexcitatory activities of Tramadol.	#EEA4A4	610.468419736812	1
Levofloxacin	Acenocoumarol	0.111	-1.625	None	2023 (1171/852)	Levofloxacin may increase the anticoagulant activities of Acenocoumarol.	#A9C9E1	919.566353780768	1
Galantamine	Risperidone	0.307	1.643	Moderate	383 (301/82)		#F3AFAF	174.094865792404	1.24828672032984e-19
Paroxetine	Risperidone	0.245	2.22	Moderate	715 (595/120)	The metabolism of Risperidone can be decreased when combined with Paroxetine.	#EEA4A4	325.007386531512	1
Acetylsalicylic acid	Ginkgo biloba	0.265	1.007	Moderate	926 (641/285)	Ginkgo biloba may increase the anticoagulant activities of Acetylsalicylic acid.	#F9BCBC	420.91865724221	1
Diltiazem	Simvastatin	0.449	-1.066	Major	975 (660/315)	The serum concentration of Simvastatin can be increased when it is combined with Diltiazem.	#B4D1E6	443.191890724789	1
Trazodone	Acenocoumarol	0.268	-1.173	None	1342 (880/462)		#B1CFE5	610.013863951453	1
Spironolactone	Losartan	0.319	1.391	Major	879 (665/214)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Losartan.	#F6B6B6	399.554535330348	1
Ciprofloxacin	Acenocoumarol	0.118	-1.689	None	1995 (1136/859)		#A8C8E1	906.838791790723	1
Hydrocortisone	Acetylsalicylic acid	0.151	1.292	Moderate	847 (629/218)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Hydrocortisone.	#F7B7B7	385.008750198868	1
Trazodone	Galantamine	0.313	-1.058	Moderate	361 (245/116)		#B4D1E6	164.094638514512	8.2744863870951e-27
Bisoprolol	Formoterol	0.276	-1.577	Moderate	923 (541/382)	Bisoprolol may decrease the bronchodilatory activities of Formoterol.	#A9C9E1	419.554989886134	1
Bisoprolol	Salmeterol	0.329	-1.741	Moderate	1112 (625/487)	Bisoprolol may decrease the bronchodilatory activities of Salmeterol.	#A6C7E0	505.466033318939	1
Acetaminophen	Warfarin	0.26	1.031	Minor	786 (548/238)	Acetaminophen may increase the anticoagulant activities of Warfarin.	#F9BCBC	357.280847291984	1
Bisoprolol	Ibuprofen	0.136	1.247	Moderate	1605 (1181/424)	Ibuprofen may decrease the antihypertensive activities of Bisoprolol.	#F7B7B7	729.562035500807	1
Omeprazole	Midazolam	0.275	1.189	Moderate	585 (425/160)		#F7B9B9	265.915134434873	1
Bisoprolol	Gliclazide	0.372	-1.1	None	691 (463/228)	Bisoprolol may increase the hypoglycemic activities of Gliclazide.	#B2D0E5	314.098047682902	1
Bisoprolol	Repaglinide	0.361	-1.35	Moderate	616 (384/232)		#AECDE3	280.006363780995	1
Acetylsalicylic acid	Insulin aspart	0.252	-1.001	Moderate	630 (435/195)	Acetylsalicylic acid may increase the hypoglycemic activities of Insulin Aspart.	#B4D1E6	286.370144776018	1
Salbutamol	Carvedilol	0.187	-1.05	Major	635 (432/203)	Carvedilol may decrease the vasoconstricting activities of Salbutamol.	#B4D1E6	288.642923702811	1
Digoxin	Amiodarone	0.333	1.009	Major	527 (365/162)	The serum concentration of Digoxin can be increased when it is combined with Amiodarone.	#F9BCBC	239.550898884066	1
Donepezil	Sertraline	0.471	1.538	Minor	346 (268/78)	The metabolism of Donepezil can be decreased when combined with Sertraline.	#F5B2B2	157.27630173413	0.143774288280528
Ibuprofen	Acenocoumarol	0.139	-1.117	None	1488 (992/496)	Ibuprofen may increase the anticoagulant activities of Acenocoumarol.	#B2D0E5	676.379008613832	1
Mirtazapine	Rivastigmine	0.335	1.826	Moderate	254 (204/50)		#F2ACAC	115.457169481125	7.90694036836538e-07
Simvastatin	Amiodarone	0.37	-1.213	Major	739 (479/260)	The serum concentration of Simvastatin can be increased when it is combined with Amiodarone.	#B1CFE5	335.916725380122	1
Levothyroxine	Iron	0.218	1.733	Moderate	492 (391/101)	The serum concentration of Levothyroxine can be decreased when it is combined with Iron.	#F2AEAE	223.641446396509	1
Mirtazapine	Donepezil	0.456	1.833	Moderate	270 (217/53)		#F2ACAC	122.730062046865	0.000930377954268795
Valproic acid	Acetylsalicylic acid	0.368	1.198	Moderate	397 (289/108)	The serum concentration of Valproic Acid can be increased when it is combined with Acetylsalicylic acid.	#F7B9B9	180.458646787427	1
Diclofenac	Alendronic acid	0.185	3.297	Moderate	435 (383/52)	The risk or severity of adverse effects can be increased when Diclofenac is combined with Alendronic acid.	#E59090	197.73176663106	1
Paroxetine	Acenocoumarol	0.348	1.287	None	589 (437/152)	Paroxetine may increase the anticoagulant activities of Acenocoumarol.	#F7B7B7	267.733357576309	1
Digoxin	Methimazole	0.291	4.05	Moderate	211 (190/21)	The serum concentration of Digoxin can be increased when it is combined with Methimazole.	#DE8080	95.911270710698	9.83483470758161e-05
Ranitidine	Acenocoumarol	0.298	-1.316	None	669 (421/248)		#AFCEE4	304.097820405009	1
Phenytoin	Omeprazole	0.359	-1.343	Moderate	466 (291/175)	The serum concentration of Omeprazole can be decreased when it is combined with Phenytoin.	#AECDE3	211.822995977181	1
Citalopram	Carvedilol	0.401	1.464	Moderate	427 (327/100)	The metabolism of Carvedilol can be decreased when combined with Citalopram.	#F5B4B4	194.09532034819	1
Omeprazole	Methotrexate	0.307	1.251	Major	315 (232/83)	The serum concentration of Methotrexate can be increased when it is combined with Omeprazole.	#F7B7B7	143.185072388009	1
Methimazole	Acenocoumarol	0.327	2.359	None	232 (195/37)	Methimazole may decrease the anticoagulant activities of Acenocoumarol.	#EDA1A1	105.456942203232	1
Diltiazem	Atorvastatin	0.47	-1.413	Moderate	431 (264/167)	The serum concentration of Diltiazem can be increased when it is combined with Atorvastatin.	#ACCCE3	195.913543489625	1
Haloperidol	Biperiden	0.385	1.621	Moderate	134 (105/29)		#F4B1B1	60.9104752380736	3.01273597387046e-15
Digoxin	Diazepam	0.234	2.248	Moderate	530 (442/88)		#EEA4A4	240.914566240142	1
Tramadol	Paroxetine	0.237	3.026	Major	551 (480/71)	Paroxetine may increase the neuroexcitatory activities of Tramadol.	#E79494	250.460237732676	1
Omeprazole	Itraconazole	0.083	1.303	Moderate	442 (329/113)	The serum concentration of Itraconazole can be decreased when it is combined with Omeprazole.	#F7B7B7	200.913657128571	1
Digoxin	Verapamil	0.322	1.507	Moderate	214 (165/49)	The metabolism of Digoxin can be decreased when combined with Verapamil.	#F5B2B2	97.2749380667742	0.0373217489960507
Azithromycin	Acenocoumarol	0.104	-1.364	None	923 (573/350)	The metabolism of Acenocoumarol can be decreased when combined with Azithromycin.	#AECDE3	419.554989886134	1
Ibuprofen	Carvedilol	0.142	1.061	Moderate	600 (422/178)	Ibuprofen may decrease the antihypertensive activities of Carvedilol.	#F9BCBC	272.733471215255	1
Amiodarone	Levofloxacin	0.156	-1.413	Major	591 (362/229)	Levofloxacin may increase the QTc-prolonging activities of Amiodarone.	#ACCCE3	268.642469147026	1
Citalopram	Clarithromycin	0.103	2.788	Major	318 (274/44)	Clarithromycin may increase the QTc-prolonging activities of Citalopram.	#E99999	144.548739744085	1
Salmeterol	Carvedilol	0.337	-1.943	Major	374 (200/174)	Carvedilol may decrease the vasoconstricting activities of Salmeterol.	#A3C5DF	170.003863724176	1
Acetylsalicylic acid	Glipizide	0.349	-1.075	Moderate	237 (160/77)	Acetylsalicylic acid may increase the hypoglycemic activities of Glipizide.	#B4D1E6	107.729721130026	1
Ramipril	Spironolactone	0.359	-1.388	Major	334 (206/128)	The risk or severity of adverse effects can be increased when Ramipril is combined with Spironolactone.	#AECDE3	151.821632309825	1
Mesalazine	Azathioprine	0.351	-1.117	Moderate	9 (6/3)	The metabolism of Azathioprine can be decreased when combined with Mesalazine.	#B2D0E5	4.09100206822882	1.31228780525313e-07
Citalopram	Propranolol	0.371	2.75	Moderate	200 (172/28)	The metabolism of Propranolol can be decreased when combined with Citalopram.	#E99999	90.9111570717516	1
Mirtazapine	Galantamine	0.471	1.977	Moderate	130 (106/24)		#F0A9A9	59.0922520966386	0.0527070702361599
Ciprofloxacin	Iron	0.228	-1.322	Moderate	710 (446/264)		#AECDE3	322.734607604718	1
Simvastatin	Clarithromycin	0.069	1.441	Major	443 (338/105)	The serum concentration of Simvastatin can be increased when it is combined with Clarithromycin.	#F5B4B4	201.36821291393	1
Fentanyl	Amiodarone	0.295	1.848	Major	282 (227/55)	The serum concentration of Fentanyl can be increased when it is combined with Amiodarone.	#F2ACAC	128.18473147117	1
Norfloxacin	Acenocoumarol	0.111	1.21	None	600 (438/162)	Norfloxacin may increase the anticoagulant activities of Acenocoumarol.	#F7B9B9	272.733471215255	1
Gliclazide	Carvedilol	0.373	-1.239	None	241 (155/86)	Carvedilol may increase the hypoglycemic activities of Gliclazide.	#AFCEE4	109.547944271461	1
Atenolol	Ibuprofen	0.18	1.424	Moderate	439 (334/105)	Ibuprofen may decrease the antihypertensive activities of Atenolol.	#F5B4B4	199.549989772495	1
Acetylsalicylic acid	Dexamethasone	0.186	-1.595	Moderate	509 (297/212)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Dexamethasone.	#A9C9E1	231.368894747608	1
Lidocaine	Bisoprolol	0.172	1.658	Moderate	254 (200/54)	The serum concentration of Lidocaine can be increased when it is combined with Bisoprolol.	#F3AFAF	115.457169481125	1
Propranolol	Ibuprofen	0.181	1.815	Moderate	283 (227/56)	Ibuprofen may decrease the antihypertensive activities of Propranolol.	#F2ACAC	128.639287256529	1
Indomethacin	Methotrexate	0.349	1.791	Major	20 (16/4)	The serum concentration of Methotrexate can be increased when it is combined with Indomethacin.	#F2AEAE	9.09111570717516	2.74284244157237e-08
Acetylsalicylic acid	Acenocoumarol	0.182	-1.617	None	1572 (912/660)	Acetylsalicylic acid may increase the anticoagulant activities of Acenocoumarol.	#A9C9E1	714.561694583968	1
Digoxin	Rabeprazole	0.232	1.603	Moderate	197 (154/43)		#F4B1B1	89.5474897156754	1
Alprazolam	Clarithromycin	0.134	2.271	Moderate	249 (208/41)	The serum concentration of Alprazolam can be increased when it is combined with Clarithromycin.	#EDA3A3	113.184390554331	1
Indomethacin	Furosemide	0.16	-1.134	Moderate	300 (199/101)	The therapeutic efficacy of Furosemide can be decreased when used in combination with Indomethacin.	#B2D0E5	136.366735607627	1
Galantamine	Sertraline	0.479	1.553	Moderate	143 (111/32)	The metabolism of Galantamine can be decreased when combined with Sertraline.	#F5B2B2	65.0014773063024	1
Omeprazole	Ketazolam	0.271	1.826	None	193 (155/38)		#F2ACAC	87.7292665742403	1
Phenytoin	Furosemide	0.361	-1.256	Minor	239 (153/86)	Phenytoin may decrease the diuretic activities of Furosemide.	#AFCEE4	108.638832700743	1
Sertraline	Carvedilol	0.431	1.161	Moderate	266 (192/74)	The metabolism of Carvedilol can be decreased when combined with Sertraline.	#F7B9B9	120.91183890543	1
Repaglinide	Carvedilol	0.41	-1.443	Moderate	186 (113/73)		#ACCCE3	84.547376076729	1
Tramadol	Escitalopram	0.284	2.396	Major	324 (273/51)	Escitalopram may increase the neuroexcitatory activities of Tramadol.	#EDA1A1	147.276074456238	1
Omeprazole	Cilostazol	0.25	-2.123	Major	275 (141/134)	The serum concentration of Cilostazol can be increased when it is combined with Omeprazole.	#9FC1DD	125.002840973658	1
Pentoxifylline	Acenocoumarol	0.328	-2.517	None	487 (229/258)	Pentoxifylline may increase the anticoagulant activities of Acenocoumarol.	#97BCD9	221.368667469715	1
Propranolol	Paroxetine	0.374	1.618	Moderate	120 (94/26)	The metabolism of Propranolol can be decreased when combined with Paroxetine.	#F4B1B1	54.546694243051	1
Formoterol	Carvedilol	0.261	-1.495	Major	232 (139/93)	Carvedilol may decrease the vasoconstricting activities of Formoterol.	#ABCBE2	105.456942203232	1
Levofloxacin	Iron	0.219	-1.347	Moderate	553 (345/208)	The serum concentration of Levofloxacin can be decreased when it is combined with Iron.	#AECDE3	251.369349303393	1
Paroxetine	Carvedilol	0.409	1.653	Moderate	183 (144/39)	The metabolism of Carvedilol can be decreased when combined with Paroxetine.	#F3AFAF	83.1837087206527	1
Repaglinide	Gliclazide	0.286	-1.312	None	173 (109/64)	Repaglinide may increase the hypoglycemic activities of Gliclazide.	#AFCEE4	78.6381508670652	1
Trimethoprim	Leucovorin	0.598	1.119	Major	56 (40/16)		#F8BABA	25.4551239800905	2.53126955949937e-07
Fluconazole	Simvastatin	0.093	1.19	Major	278 (202/76)	The serum concentration of Simvastatin can be increased when it is combined with Fluconazole.	#F7B9B9	126.366508329735	1
Sertraline	Clarithromycin	0.087	2.624	Moderate	199 (170/29)	The metabolism of Sertraline can be decreased when combined with Clarithromycin.	#EB9C9C	90.4566012863929	1
Propafenone	Acenocoumarol	0.314	1.289	None	97 (72/25)	The serum concentration of Acenocoumarol can be increased when it is combined with Propafenone.	#F7B7B7	44.0919111797995	1
Carbamazepine	Simvastatin	0.39	-1.096	Moderate	158 (106/52)	The metabolism of Simvastatin can be increased when combined with Carbamazepine.	#B2D0E5	71.8198140866838	1
Bisoprolol	Insulin detemir	0.353	-1.039	Moderate	211 (144/67)		#B4D1E6	95.911270710698	1
Propranolol	Sertraline	0.36	1.729	Moderate	141 (112/29)	The metabolism of Propranolol can be decreased when combined with Sertraline.	#F2AEAE	64.0923657355849	1
Trospium	Ketotifen	0.358	Inf	None	3 (3/0)		#B32020	1.36366735607627	0.141763793334565
Tramadol	Fluoxetine	0.289	3.922	Major	205 (184/21)	Fluoxetine may increase the neuroexcitatory activities of Tramadol.	#DF8383	93.1839359985454	1
Lorazepam	Phenytoin	0.376	1.134	Moderate	159 (114/45)	The serum concentration of Phenytoin can be increased when it is combined with Lorazepam.	#F8BABA	72.2743698720425	1
Digoxin	Telmisartan	0.243	1.981	Moderate	179 (146/33)	The serum concentration of Digoxin can be increased when it is combined with Telmisartan.	#F0A9A9	81.3654855792177	1
Trimethoprim	Rifampicin	0.594	-1.276	Moderate	33 (21/12)	The metabolism of Trimethoprim can be increased when combined with Rifampicin.	#AFCEE4	15.000340916839	1.50683691633293e-10
Atenolol	Salbutamol	0.182	-1.128	Moderate	316 (210/106)	Atenolol may decrease the bronchodilatory activities of Salbutamol.	#B2D0E5	143.639628173368	1
Diltiazem	Amiodarone	0.34	1.087	Major	168 (119/49)	The risk or severity of bradycardia can be increased when Diltiazem is combined with Amiodarone.	#F8BABA	76.3653719402714	1
Folic acid	Phenytoin	0.31	-1.019	Moderate	83 (57/26)	The serum concentration of Phenytoin can be decreased when it is combined with Folic Acid.	#B4D1E6	37.7281301847769	0.383234247410148
Fluoxetine	Risperidone	0.297	1.893	Moderate	183 (148/35)	The metabolism of Risperidone can be decreased when combined with Fluoxetine.	#F1ABAB	83.1837087206527	1
Atenolol	Gliclazide	0.376	1.099	None	152 (108/44)	Atenolol may increase the hypoglycemic activities of Gliclazide.	#F8BABA	69.0924793745312	1
Moxifloxacin	Acenocoumarol	0.11	-1.444	None	377 (229/148)		#ACCCE3	171.367531080252	1
Furosemide	Gentamicin	0.145	1.919	Major	185 (150/35)	The serum concentration of Gentamicin can be increased when it is combined with Furosemide.	#F1ABAB	84.0928202913703	1
Fluoxetine	Acenocoumarol	0.281	1.561	None	184 (143/41)	The metabolism of Acenocoumarol can be decreased when combined with Fluoxetine.	#F4B1B1	83.6382645060115	1
Fluconazole	Fentanyl	0.29	1.56	Major	157 (122/35)	The serum concentration of Fentanyl can be increased when it is combined with Fluconazole.	#F4B1B1	71.365258301325	1
Amitriptyline	Salbutamol	0.174	1.967	Moderate	178 (145/33)	The risk or severity of adverse effects can be increased when Amitriptyline is combined with Salbutamol.	#F0A9A9	80.910929793859	1
Warfarin	Amiodarone	0.354	-1.718	Major	92 (52/40)	The therapeutic efficacy of Warfarin can be increased when used in combination with Amiodarone.	#A6C7E0	41.8191322530057	0.000277253127633232
Methotrexate	Hydroxychloroquine	0.382	1.119	Minor	7 (5/2)		#F8BABA	3.18189049751131	0.000158404769520312
Amitriptyline	Carbamazepine	0.374	1.393	Moderate	37 (28/9)	The metabolism of Amitriptyline can be increased when combined with Carbamazepine.	#F6B6B6	16.8185640582741	3.32465724537908e-06
Alendronic acid	Naproxen	0.182	3.24	Moderate	173 (152/21)	The risk or severity of adverse effects can be increased when Naproxen is combined with Alendronic acid.	#E59090	78.6381508670652	1
Phenytoin	Ciprofloxacin	0.118	-1.117	Moderate	126 (84/42)	The therapeutic efficacy of Phenytoin can be decreased when used in combination with Ciprofloxacin.	#B2D0E5	57.2740289552035	1
Bisoprolol	Insulin aspart	0.282	-1.034	Moderate	177 (121/56)		#B4D1E6	80.4563740085002	1
Omeprazole	Flurazepam	0.2	-1.042	Moderate	132 (90/42)		#B4D1E6	60.0013636673561	1
Diltiazem	Amlodipine	0.314	1.36	Moderate	327 (246/81)	The metabolism of Amlodipine can be decreased when combined with Diltiazem.	#F6B6B6	148.639741812314	1
Haloperidol	Propranolol	0.256	1.667	Moderate	137 (108/29)	The metabolism of Propranolol can be decreased when combined with Haloperidol.	#F3AFAF	62.2741425941499	1
Sumatriptan	Ergotamine	0.778	-1.117	Major	3 (2/1)	Ergotamine may increase the vasoconstricting activities of Sumatriptan.	#B2D0E5	1.36366735607627	0.0740846747850999
Fluconazole	Alprazolam	0.15	2.07	Major	135 (111/24)	The metabolism of Alprazolam can be decreased when combined with Fluconazole.	#F0A7A7	61.3650310234324	1
Carvedilol	Insulin detemir	0.336	1.129	Moderate	81 (58/23)		#F8BABA	36.8190186140594	1
Digoxin	Indapamide	0.248	1.949	Moderate	166 (135/31)	The risk or severity of adverse effects can be increased when Indapamide is combined with Digoxin.	#F1ABAB	75.4562603695539	1
Oxycodone	Sertraline	0.375	2.204	Moderate	77 (64/13)	The metabolism of Oxycodone can be decreased when combined with Sertraline.	#EEA4A4	35.0007954726244	1
Erythromycin	Alprazolam	0.125	4.421	Moderate	87 (79/8)	The serum concentration of Alprazolam can be increased when it is combined with Erythromycin.	#DA7878	39.546353326212	1
Dextromethorphan	Memantine	0.137	3.038	Minor	109 (95/14)	The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Memantine.	#E79494	49.5465806041046	1
Gemfibrozil	Acenocoumarol	0.254	1.204	None	107 (78/29)	The metabolism of Acenocoumarol can be decreased when combined with Gemfibrozil.	#F7B9B9	48.6374690333871	1
Propranolol	Salbutamol	0.2	1.29	Major	163 (121/42)		#F7B7B7	74.0925930134776	1
Duloxetine	Ciprofloxacin	0.154	1.733	Major	151 (120/31)		#F2AEAE	68.6379235891725	1
Dextromethorphan	Paroxetine	0.107	2.791	Major	123 (106/17)	Paroxetine may increase the serotonergic activities of Dextromethorphan.	#E99999	55.9103615991273	1
Glyburide	Carvedilol	0.351	-1.183	Moderate	104 (68/36)	Carvedilol may increase the hypoglycemic activities of Glyburide.	#B1CFE5	47.2738016773108	1
Clarithromycin	Acenocoumarol	0.108	1.096	None	238 (169/69)	The metabolism of Acenocoumarol can be decreased when combined with Clarithromycin.	#F8BABA	108.184276915384	1
Spironolactone	Captopril	0.383	1.277	Major	131 (97/34)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Captopril.	#F7B7B7	59.5468078819973	1
Galantamine	Paroxetine	0.416	1.414	Moderate	79 (60/19)	The metabolism of Galantamine can be decreased when combined with Paroxetine.	#F5B4B4	35.9099070433419	1
Spironolactone	Tolevamer	0.266	1.002	Moderate	68 (47/21)		#F9BCBC	30.9097934043956	1
Moxifloxacin	Amiodarone	0.156	-1.152	Major	144 (95/49)	Moxifloxacin may increase the QTc-prolonging activities of Amiodarone.	#B2D0E5	65.4560330916612	1
Metoclopramide	Levodopa	0.125	1.452	Moderate	157 (120/37)	The therapeutic efficacy of Levodopa can be decreased when used in combination with Metoclopramide.	#F5B4B4	71.365258301325	1
Allopurinol	Warfarin	0.279	-2.317	Moderate	110 (54/56)	Allopurinol may increase the anticoagulant activities of Warfarin.	#9CBFDB	50.0011363894634	1
Spironolactone	Irbesartan	0.301	1.149	Major	132 (95/37)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Irbesartan.	#F8BABA	60.0013636673561	1
Fenofibrate	Acenocoumarol	0.289	1.019	None	95 (66/29)	Fenofibrate may increase the anticoagulant activities of Acenocoumarol.	#F9BCBC	43.182799609082	1
Phenytoin	Alprazolam	0.439	2.288	Moderate	55 (46/9)	The serum concentration of Phenytoin can be increased when it is combined with Alprazolam.	#EDA3A3	25.0005681947317	1
Olanzapine	Donepezil	0.35	1.418	Moderate	50 (38/12)		#F5B4B4	22.7277892679379	1
Carbamazepine	Atorvastatin	0.374	1.439	Moderate	59 (45/14)	The metabolism of Atorvastatin can be increased when combined with Carbamazepine.	#F5B4B4	26.8187913361667	1
Citalopram	Oxycodone	0.32	3.432	Moderate	78 (69/9)	The metabolism of Oxycodone can be decreased when combined with Citalopram.	#E38D8D	35.4553512579831	1
Acetylsalicylic acid	Insulin glulisine	0.163	1.05	Moderate	87 (61/26)	Acetylsalicylic acid may increase the hypoglycemic activities of Insulin Glulisine.	#F9BCBC	39.546353326212	1
Clarithromycin	Quetiapine	0.138	1.638	Major	205 (161/44)	The serum concentration of Quetiapine can be increased when it is combined with Clarithromycin.	#F3AFAF	93.1839359985454	1
Carvedilol	Escitalopram	0.377	1.04	None	113 (79/34)		#F9BCBC	51.3648037455397	1
Triamcinolone	Acetylsalicylic acid	0.1	-1.299	Moderate	155 (98/57)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Triamcinolone.	#AFCEE4	70.4561467306075	1
Cloxacillin	Acenocoumarol	0.09	-1.436	None	230 (140/90)	Cloxacillin may decrease the anticoagulant activities of Acenocoumarol.	#ACCCE3	104.547830632514	1
Atenolol	Glyburide	0.339	-1.137	Moderate	86 (57/29)	Atenolol may increase the hypoglycemic activities of Glyburide.	#B2D0E5	39.0917975408532	1
Methotrexate	Acetylsalicylic acid	0.275	1.01	Major	114 (79/35)	The serum concentration of Methotrexate can be increased when it is combined with Acetylsalicylic acid.	#F9BCBC	51.8193595308984	1
Fluoxetine	Propranolol	0.351	8.282	Moderate	39 (37/2)	The metabolism of Propranolol can be decreased when combined with Fluoxetine.	#B82C2C	17.7276756289916	1
Erythromycin	Citalopram	0.086	3.313	Major	84 (74/10)	The metabolism of Citalopram can be decreased when combined with Erythromycin.	#E48E8E	38.1826859701357	1
Pravastatin	Fenofibrate	0.769	1.262	Major	42 (31/11)	The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibrate is combined with Pravastatin.	#F7B7B7	19.0913429850678	1
Hydrocortisone	Acenocoumarol	0.184	1.054	None	161 (113/48)		#F9BCBC	73.1834814427601	1
Omeprazole	Triazolam	0.295	1.641	Moderate	70 (55/15)		#F3AFAF	31.8189049751131	1
Atenolol	Repaglinide	0.295	1.094	Moderate	93 (66/27)		#F8BABA	42.2736880383645	1
Erythromycin	Simvastatin	0.089	1.567	Major	126 (98/28)	The serum concentration of Simvastatin can be increased when it is combined with Erythromycin.	#F4B1B1	57.2740289552035	1
Simvastatin	Colchicine	0.165	-3.365	Major	193 (77/116)	Colchicine may increase the myopathic rhabdomyolysis activities of Simvastatin.	#88B0D3	87.7292665742403	1
Methylprednisolone	Clarithromycin	0.502	2.064	Major	101 (83/18)	The serum concentration of Methylprednisolone can be increased when it is combined with Clarithromycin.	#F0A7A7	45.9101343212346	1
Levofloxacin	Methotrimeprazine	0.261	-1.204	Moderate	177 (115/62)	Methotrimeprazine may increase the QTc-prolonging activities of Levofloxacin.	#B1CFE5	80.4563740085002	1
Pyridostigmine	Prednisone	0.423	-1.582	Moderate	41 (24/17)	The risk or severity of adverse effects can be increased when Prednisone is combined with Pyridostigmine.	#A9C9E1	18.6367871997091	0.0330360965276177
Bisoprolol	Glyburide	0.296	-1.108	Moderate	181 (121/60)	Bisoprolol may increase the hypoglycemic activities of Glyburide.	#B2D0E5	82.2745971499352	1
Escitalopram	Rasagiline	0.436	-1.726	Major	39 (22/17)	The risk or severity of adverse effects can be increased when Escitalopram is combined with Rasagiline.	#A6C7E0	17.7276756289916	0.0139661190898441
Fenofibrate	Atorvastatin	0.41	-1.403	Major	70 (43/27)	The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibrate is combined with Atorvastatin.	#ACCCE3	31.8189049751131	1
Lovastatin	Diltiazem	0.42	1.03	Major	66 (46/20)	The serum concentration of Lovastatin can be increased when it is combined with Diltiazem.	#F9BCBC	30.000681833678	1
Digoxin	Clarithromycin	0.169	1.452	Major	174 (133/41)	The metabolism of Digoxin can be decreased when combined with Clarithromycin.	#F5B4B4	79.0927066524239	1
Carvedilol	Insulin aspart	0.223	-1.291	Moderate	71 (45/26)		#AFCEE4	32.2734607604718	1
Lovastatin	Acenocoumarol	0.302	1.02	None	118 (82/36)	The metabolism of Acenocoumarol can be decreased when combined with Lovastatin.	#F9BCBC	53.6375826723335	1
Propranolol	Primidone	0.356	-1.675	Moderate	14 (8/6)	The metabolism of Propranolol can be increased when combined with Primidone.	#A8C8E1	6.36378099502261	0.000354580142928195
Donepezil	Tolterodine	0.39	-1.191	Moderate	69 (45/24)	The therapeutic efficacy of Tolterodine can be decreased when used in combination with Donepezil.	#B1CFE5	31.3643491897543	1
Alprazolam	Carbamazepine	0.35	2.686	Moderate	56 (48/8)	The metabolism of Alprazolam can be increased when combined with Carbamazepine.	#EA9B9B	25.4551239800905	1
Chlorthalidone	Digoxin	0.272	1.768	Moderate	99 (79/20)	The risk or severity of adverse effects can be increased when Chlorthalidone is combined with Digoxin.	#F2AEAE	45.0010227505171	1
Propranolol	Escitalopram	0.328	1.471	None	60 (46/14)		#F5B4B4	27.2733471215255	1
Venlafaxine	Metoclopramide	0.158	1.97	Moderate	108 (88/20)	The risk or severity of adverse effects can be increased when Metoclopramide is combined with Venlafaxine.	#F0A9A9	49.0920248187459	1
Hydroxyzine	Donepezil	0.243	1.276	Moderate	77 (57/20)		#F7B7B7	35.0007954726244	1
Phenytoin	Quetiapine	0.344	-1.14	Major	74 (49/25)	The serum concentration of Quetiapine can be decreased when it is combined with Phenytoin.	#B2D0E5	33.6371281165481	1
Atorvastatin	Clarithromycin	0.126	-1.072	Major	148 (100/48)	The serum concentration of Atorvastatin can be increased when it is combined with Clarithromycin.	#B4D1E6	67.2742562330962	1
Fluconazole	Haloperidol	0.366	1.301	Major	125 (93/32)	The metabolism of Haloperidol can be decreased when combined with Fluconazole.	#F7B7B7	56.8194731698448	1
Repaglinide	Glyburide	0.27	1.238	None	64 (47/17)	Repaglinide may increase the hypoglycemic activities of Glyburide.	#F7B9B9	29.0915702629605	1
Torasemide	Indomethacin	0.193	1.09	Moderate	79 (56/23)	The therapeutic efficacy of Torasemide can be decreased when used in combination with Indomethacin.	#F8BABA	35.9099070433419	1
Carbamazepine	Risperidone	0.288	1.272	Moderate	73 (54/19)	The serum concentration of Risperidone can be decreased when it is combined with Carbamazepine.	#F7B7B7	33.1825723311893	1
Ranolazine	Simvastatin	0.466	-2.656	Major	81 (37/44)	The serum concentration of Simvastatin can be increased when it is combined with Ranolazine.	#96BBD9	36.8190186140594	1
Ciprofloxacin	Rasagiline	0.12	-2.105	Major	101 (52/49)		#A0C3DD	45.9101343212346	1
Fluoxetine	Carvedilol	0.278	1.243	Moderate	68 (50/18)	The metabolism of Carvedilol can be decreased when combined with Fluoxetine.	#F7B7B7	30.9097934043956	1
Acarbose	Digoxin	0.313	1.418	Moderate	50 (38/12)	The serum concentration of Digoxin can be decreased when it is combined with Acarbose.	#F5B4B4	22.7277892679379	1
Mirtazapine	Rasagiline	0.448	-1.117	Major	39 (26/13)	The risk or severity of adverse effects can be increased when Rasagiline is combined with Mirtazapine.	#B2D0E5	17.7276756289916	1
Spironolactone	Lisinopril	0.207	1.104	Major	149 (106/43)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Lisinopril.	#F8BABA	67.728812018455	1
Citalopram	Warfarin	0.305	1.321	Moderate	79 (59/20)	The metabolism of Warfarin can be decreased when combined with Citalopram.	#F6B6B6	35.9099070433419	1
Omeprazole	Halazepam	0.192	2.139	Moderate	52 (43/9)		#EFA6A6	23.6369008386554	1
Salbutamol	Clomipramine	0.182	1.88	Moderate	52 (42/10)	The risk or severity of adverse effects can be increased when Clomipramine is combined with Salbutamol.	#F1ABAB	23.6369008386554	1
Cholestyramine	Ursodeoxycholic acid	0.327	1.194	None	11 (8/3)	The serum concentration of Ursodeoxycholic acid can be decreased when it is combined with Cholestyramine.	#F7B9B9	5.00011363894634	0.0630504927979749
Verapamil	Atorvastatin	0.411	1.038	Moderate	73 (51/22)	Atorvastatin can cause a decrease in the absorption of Verapamil resulting in a reduced serum concentration and potentially a decrease in efficacy.	#F9BCBC	33.1825723311893	1
Phenytoin	Sertraline	0.408	1.343	Moderate	44 (33/11)	The serum concentration of Phenytoin can be increased when it is combined with Sertraline.	#F6B6B6	20.0004545557854	1
Sucralfate	Lansoprazole	0.228	1.144	Moderate	32 (23/9)		#F8BABA	14.5457851314803	1
Atenolol	Salmeterol	0.245	-1.655	Moderate	141 (81/60)	Atenolol may decrease the bronchodilatory activities of Salmeterol.	#A8C8E1	64.0923657355849	1
Spironolactone	Telmisartan	0.233	2.078	Major	79 (65/14)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Telmisartan.	#F0A7A7	35.9099070433419	1
Fluoxetine	Selegiline	0.392	3.581	Major	9 (8/1)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Selegiline.	#E28989	4.09100206822882	1
Phenylbutazone	Gliclazide	0.04	Inf	None	1 (1/0)		#B32020	0.454555785358758	1
Erythromycin	Sertraline	0.11	7.312	Moderate	52 (49/3)	The risk or severity of adverse effects can be increased when Erythromycin is combined with Sertraline.	#C13F3F	23.6369008386554	1
Fluoxetine	Dextromethorphan	0.163	1.97	Major	54 (44/10)	Fluoxetine may increase the serotonergic activities of Dextromethorphan.	#F0A9A9	24.5460124093729	1
Amitriptyline	Fluoxetine	0.386	3.357	Major	34 (30/4)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Amitriptyline.	#E48E8E	15.4548967021978	1
Simvastatin	Gemfibrozil	0.223	1.94	Major	80 (65/15)	The risk or severity of rhabdomyolysis. myoglobinuria. and elevated creatine kinase (CPK) can be increased when Gemfibrozil is combined with Simvastatin.	#F1ABAB	36.3644628287007	1
Prednisone	Warfarin	0.178	-1.318	Moderate	97 (61/36)	Prednisone may increase the anticoagulant activities of Warfarin.	#AECDE3	44.0919111797995	1
Haloperidol	Carbamazepine	0.225	1.709	Moderate	53 (42/11)	The metabolism of Haloperidol can be increased when combined with Carbamazepine.	#F3AFAF	24.0914566240142	1
Simvastatin	Itraconazole	0.087	1.414	Major	79 (60/19)	The serum concentration of Simvastatin can be increased when it is combined with Itraconazole.	#F5B4B4	35.9099070433419	1
Norfloxacin	Iron	0.24	1.332	None	163 (122/41)	The serum concentration of Norfloxacin can be decreased when it is combined with Iron.	#F6B6B6	74.0925930134776	1
Trazodone	Warfarin	0.273	-1.391	Minor	86 (53/33)	Trazodone may decrease the anticoagulant activities of Warfarin.	#AECDE3	39.0917975408532	1
Fluvastatin	Acenocoumarol	0.297	-1.798	None	74 (41/33)	The metabolism of Acenocoumarol can be decreased when combined with Fluvastatin.	#A5C6DF	33.6371281165481	1
Simvastatin	Fenofibrate	0.392	-1.387	Major	94 (58/36)	The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibrate is combined with Simvastatin.	#AECDE3	42.7282438237233	1
Carbamazepine	Sertraline	0.349	1.424	Moderate	46 (35/11)	The metabolism of Carbamazepine can be decreased when combined with Sertraline.	#F5B4B4	20.9095661265029	1
Levothyroxine	Warfarin	0.28	-1.117	Moderate	69 (46/23)	Levothyroxine may increase the anticoagulant activities of Warfarin.	#B2D0E5	31.3643491897543	1
Naproxen	Acenocoumarol	0.12	-1.448	None	206 (125/81)	Naproxen may increase the anticoagulant activities of Acenocoumarol.	#ACCCE3	93.6384917839042	1
Donepezil	Methotrimeprazine	0.257	1.268	Moderate	46 (34/12)	The metabolism of Donepezil can be decreased when combined with Methotrimeprazine.	#F7B7B7	20.9095661265029	1
Citalopram	Rasagiline	0.401	-1.117	Major	48 (32/16)	The risk or severity of adverse effects can be increased when Citalopram is combined with Rasagiline.	#B2D0E5	21.8186776972204	1
Salbutamol	Rasagiline	0.166	-2.048	Moderate	69 (36/33)	The risk or severity of adverse effects can be increased when Rasagiline is combined with Salbutamol.	#A0C3DD	31.3643491897543	1
Glimepiride	Repaglinide	0.219	-1.489	None	45 (27/18)	Glimepiride may increase the hypoglycemic activities of Repaglinide.	#ABCBE2	20.4550103411441	1
Phenytoin	Diazepam	0.332	-1.197	Moderate	43 (28/15)	The serum concentration of Phenytoin can be increased when it is combined with Diazepam.	#B1CFE5	19.5458987704266	1
Betamethasone	Acetylsalicylic acid	0.077	-1.236	Moderate	73 (47/26)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Betamethasone.	#B1CFE5	33.1825723311893	1
Fluoxetine	Sumatriptan	0.144	Inf	Major	5 (5/0)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Sumatriptan.	#B32020	2.27277892679379	1
Gentamicin	Cefoxitin	1	Inf	Moderate	1 (1/0)		#B32020	0.454555785358758	1
Olanzapine	Rivastigmine	0.346	-1.582	Moderate	41 (24/17)		#A9C9E1	18.6367871997091	1
Sertraline	Rasagiline	0.446	-1.375	Major	42 (26/16)	The risk or severity of adverse effects can be increased when Sertraline is combined with Rasagiline.	#AECDE3	19.0913429850678	1
Omeprazole	Ketoconazole	0.134	-1.635	Moderate	71 (41/30)	The serum concentration of Ketoconazole can be decreased when it is combined with Omeprazole.	#A9C9E1	32.2734607604718	1
Propranolol	Gliclazide	0.342	-1.229	None	62 (40/22)	Propranolol may increase the hypoglycemic activities of Gliclazide.	#B1CFE5	28.182458692243	1
Ranitidine	Procainamide	0.5	Inf	Moderate	1 (1/0)	The serum concentration of Procainamide can be increased when it is combined with Ranitidine.	#B32020	0.454555785358758	1
Phenytoin	Acenocoumarol	0.334	-1.69	None	65 (37/28)	Phenytoin may increase the anticoagulant activities of Acenocoumarol.	#A8C8E1	29.5461260483193	1
Phenytoin	Lamotrigine	0.366	-3.127	Moderate	12 (5/7)	The serum concentration of Lamotrigine can be decreased when it is combined with Phenytoin.	#8CB4D5	5.4546694243051	0.000335987223304383
Diltiazem	Carbamazepine	0.319	5.372	Major	26 (24/2)	The serum concentration of Carbamazepine can be increased when it is combined with Diltiazem.	#D26565	11.8184504193277	1
Atorvastatin	Colchicine	0.22	-3.56	Major	83 (32/51)	The risk or severity of adverse effects can be increased when Colchicine is combined with Atorvastatin.	#83ADD1	37.7281301847769	1
Folic acid	Phenobarbital	0.322	-1.489	Moderate	35 (21/14)	The serum concentration of Phenobarbital can be decreased when it is combined with Folic Acid.	#ABCBE2	15.9094524875565	1
Olanzapine	Galantamine	0.443	1.268	Moderate	23 (17/6)		#F7B7B7	10.4547830632514	1
Warfarin	Levofloxacin	0.114	-1.261	Major	97 (62/35)	Levofloxacin may increase the anticoagulant activities of Warfarin.	#AFCEE4	44.0919111797995	1
Azithromycin	Lovastatin	0.062	1.099	Moderate	76 (54/22)	The serum concentration of Lovastatin can be increased when it is combined with Azithromycin.	#F8BABA	34.5462396872656	1
Diazepam	Clarithromycin	0.271	2.872	Moderate	89 (77/12)	The metabolism of Diazepam can be decreased when combined with Clarithromycin.	#E89898	40.4554648969295	1
Prazosin	Verapamil	0.346	Inf	Moderate	2 (2/0)	The risk or severity of hypotension can be increased when Prazosin is combined with Verapamil.	#B32020	0.909111570717516	1
Donepezil	Solifenacin	0.387	-2.399	Moderate	56 (27/29)	The therapeutic efficacy of Solifenacin can be decreased when used in combination with Donepezil.	#9ABEDB	25.4551239800905	1
Glyburide	Glucosamine	0.195	2.984	None	23 (20/3)		#E79494	10.4547830632514	1
Bisoprolol	Glipizide	0.39	-1.083	Moderate	49 (33/16)	Bisoprolol may increase the hypoglycemic activities of Glipizide.	#B2D0E5	22.2732334825792	1
Atenolol	Formoterol	0.233	-1.724	Moderate	101 (57/44)	Atenolol may decrease the bronchodilatory activities of Formoterol.	#A6C7E0	45.9101343212346	1
Rivastigmine	Methotrimeprazine	0.25	1.253	Moderate	38 (28/10)		#F7B7B7	17.2731198436328	1
Atenolol	Diltiazem	0.246	1.368	Major	73 (55/18)	Diltiazem may increase the hypotensive activities of Atenolol.	#F6B6B6	33.1825723311893	1
Metformin	Glucosamine	0.217	1.078	None	75 (53/22)		#F9BCBC	34.0916839019069	1
Almotriptan	Ketoconazole	0.05	Inf	Moderate	1 (1/0)	The serum concentration of Almotriptan can be increased when it is combined with Ketoconazole.	#B32020	0.454555785358758	1
Carbamazepine	Acenocoumarol	0.325	-1.564	None	68 (40/28)	The serum concentration of Acenocoumarol can be decreased when it is combined with Carbamazepine.	#A9C9E1	30.9097934043956	1
Digoxin	Propafenone	0.26	-1.042	Moderate	44 (30/14)	The serum concentration of Digoxin can be increased when it is combined with Propafenone.	#B4D1E6	20.0004545557854	1
Propranolol	Formoterol	0.245	1.027	Major	56 (39/17)		#F9BCBC	25.4551239800905	1
Galantamine	Tolterodine	0.476	1.045	Moderate	30 (21/9)	The therapeutic efficacy of Tolterodine can be decreased when used in combination with Galantamine.	#F9BCBC	13.6366735607627	1
Tacrolimus	Danazol	0.135	Inf	Moderate	1 (1/0)	The serum concentration of Tacrolimus can be increased when it is combined with Danazol.	#B32020	0.454555785358758	1
Propranolol	Salmeterol	0.245	-1.39	Major	73 (45/28)		#AECDE3	33.1825723311893	1
Fluoxetine	Clarithromycin	0.154	2.014	Moderate	44 (36/8)	Clarithromycin may increase the QTc-prolonging activities of Fluoxetine.	#F0A9A9	20.0004545557854	1
Lidocaine	Carvedilol	0.152	1.506	Moderate	48 (37/11)	The serum concentration of Lidocaine can be increased when it is combined with Carvedilol.	#F5B2B2	21.8186776972204	1
Dihydroergotamine	Nadolol	0.043	Inf	Moderate	1 (1/0)	Dihydroergotamine may increase the atrioventricular blocking (AV block) activities of Nadolol.	#B32020	0.454555785358758	1
Risperidone	Itraconazole	0.148	1.835	None	51 (41/10)	The metabolism of Risperidone can be decreased when combined with Itraconazole.	#F2ACAC	23.1823450532967	1
Disopyramide	Propranolol	0.095	Inf	Major	1 (1/0)	Disopyramide may increase the bradycardic activities of Propranolol.	#B32020	0.454555785358758	1
Amiodarone	Clarithromycin	0.143	1.066	Major	71 (50/21)	Clarithromycin may increase the QTc-prolonging activities of Amiodarone.	#F9BCBC	32.2734607604718	1
Chlorpromazine	Bromocriptine	1	Inf	Moderate	1 (1/0)	The therapeutic efficacy of Chlorpromazine can be decreased when used in combination with Bromocriptine.	#B32020	0.454555785358758	1
Carbamazepine	Levetiracetam	0.351	-1.015	Moderate	16 (11/5)	The risk or severity of adverse effects can be increased when Carbamazepine is combined with Levetiracetam.	#B4D1E6	7.27289256574013	1
Phenytoin	Gabapentin	0.35	1.268	Moderate	23 (17/6)	The risk or severity of adverse effects can be increased when Gabapentin is combined with Phenytoin.	#F7B7B7	10.4547830632514	1
Propranolol	Glyburide	0.267	1.535	Moderate	31 (24/7)	Propranolol may increase the hypoglycemic activities of Glyburide.	#F5B2B2	14.0912293461215	1
Lovastatin	Verapamil	0.548	3.357	Major	17 (15/2)	The serum concentration of Lovastatin can be increased when it is combined with Verapamil.	#E48E8E	7.72744835109889	1
Hydroxyzine	Rivastigmine	0.171	1.015	Moderate	49 (34/15)		#F9BCBC	22.2732334825792	1
Methotrexate	Amoxicillin	0.147	1.373	Major	61 (46/15)	The serum concentration of Methotrexate can be increased when it is combined with Amoxicillin.	#F6B6B6	27.7279029068842	1
Tramadol	Carbamazepine	0.245	-1.066	Moderate	65 (44/21)	Tramadol may increase the central nervous system depressant (CNS depressant) activities of Carbamazepine.	#B4D1E6	29.5461260483193	1
Warfarin	Ranitidine	0.314	-1.197	Moderate	43 (28/15)	The serum concentration of Warfarin can be increased when it is combined with Ranitidine.	#B1CFE5	19.5458987704266	1
Amitriptyline	Duloxetine	0.417	8.058	Major	19 (18/1)	Duloxetine may increase the serotonergic activities of Amitriptyline.	#BA3131	8.6365599218164	1
Phenytoin	Mirtazapine	0.268	4.477	Moderate	22 (20/2)	Phenytoin may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.	#DA7878	10.0002272778927	1
Fluconazole	Atorvastatin	0.109	-1.303	Major	76 (48/28)	The serum concentration of Atorvastatin can be increased when it is combined with Fluconazole.	#AFCEE4	34.5462396872656	1
Bisoprolol	Terbutaline	0.139	-1.411	Moderate	93 (57/36)	Bisoprolol may decrease the bronchodilatory activities of Terbutaline.	#ACCCE3	42.2736880383645	1
Ziprasidone	Donepezil	0.493	1.119	Moderate	7 (5/2)	The metabolism of Donepezil can be decreased when combined with Ziprasidone.	#F8BABA	3.18189049751131	1
Ciprofloxacin	Warfarin	0.148	-1.881	Major	105 (57/48)		#A3C5DF	47.7283574626696	1
Warfarin	Ibuprofen	0.148	1.082	Major	82 (58/24)	Ibuprofen may increase the anticoagulant activities of Warfarin.	#F8BABA	37.2735743994182	1
Fluconazole	Acenocoumarol	0.101	-1.557	None	112 (66/46)	The serum concentration of Acenocoumarol can be increased when it is combined with Fluconazole.	#A9C9E1	50.9102479601809	1
Alprazolam	Itraconazole	0.116	3.469	Major	35 (31/4)	The serum concentration of Alprazolam can be increased when it is combined with Itraconazole.	#E38B8B	15.9094524875565	1
Lovastatin	Carbamazepine	0.435	1.492	None	13 (10/3)	The metabolism of Lovastatin can be increased when combined with Carbamazepine.	#F5B2B2	5.90922520966386	1
Trazodone	Ginkgo biloba	0.204	1.475	Moderate	73 (56/17)		#F5B4B4	33.1825723311893	1
Fluoxetine	Clomipramine	0.33	2.238	Major	12 (10/2)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Clomipramine.	#EEA4A4	5.4546694243051	1
Nortriptyline	Rivastigmine	0.301	Inf	Moderate	5 (5/0)		#B32020	2.27277892679379	1
Trospium	Amitriptyline	0.423	3.134	Moderate	8 (7/1)		#E69393	3.63644628287007	1
Ergotamine	Almotriptan	1	Inf	Major	1 (1/0)	Ergotamine may increase the vasoconstricting activities of Almotriptan.	#B32020	0.454555785358758	1
Procyclidine	Haloperidol	0.37	Inf	Moderate	2 (2/0)		#B32020	0.909111570717516	1
Phenytoin	Prednisone	0.139	-1.266	Moderate	47 (30/17)	The serum concentration of Prednisone can be decreased when it is combined with Phenytoin.	#AFCEE4	21.3641219118616	1
Gentamicin	Cefuroxime	0.646	1.442	Moderate	38 (29/9)		#F5B4B4	17.2731198436328	1
Atorvastatin	Gemfibrozil	0.236	1.343	Major	36 (27/9)	The risk or severity of adverse effects can be increased when Gemfibrozil is combined with Atorvastatin.	#F6B6B6	16.3640082729153	1
Erythromycin	Quetiapine	0.097	2.288	Major	55 (46/9)	The metabolism of Quetiapine can be decreased when combined with Erythromycin.	#EDA3A3	25.0005681947317	1
Topiramate	Carbamazepine	0.543	1.791	Moderate	5 (4/1)	The serum concentration of Topiramate can be decreased when it is combined with Carbamazepine.	#F2AEAE	2.27277892679379	1
Valproic acid	Nimodipine	0.432	5.372	Minor	13 (12/1)		#D26565	5.90922520966386	1
Methotrexate	Naproxen	0.303	1.94	Major	16 (13/3)	The serum concentration of Methotrexate can be increased when it is combined with Naproxen.	#F1ABAB	7.27289256574013	1
Metronidazole	Acenocoumarol	0.122	1.211	None	63 (46/17)	The serum concentration of Acenocoumarol can be increased when it is combined with Metronidazole.	#F7B9B9	28.6370144776018	1
Terbutaline	Carvedilol	0.153	-1.632	Major	45 (26/19)	Carvedilol may decrease the vasoconstricting activities of Terbutaline.	#A9C9E1	20.4550103411441	1
Repaglinide	Clarithromycin	0.112	1.309	Moderate	51 (38/13)	The serum concentration of Repaglinide can be increased when it is combined with Clarithromycin.	#F7B7B7	23.1823450532967	1
Fluvoxamine	Doxepin	0.068	Inf	Major	1 (1/0)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Doxepin.	#B32020	0.454555785358758	1
Metoprolol	Ibuprofen	0.133	1.144	Moderate	32 (23/9)	Ibuprofen may decrease the antihypertensive activities of Metoprolol.	#F8BABA	14.5457851314803	1
Fluvoxamine	Mirtazapine	0.351	2.388	Major	19 (16/3)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Mirtazapine.	#EDA1A1	8.6365599218164	1
Propranolol	Ergotamine	0.375	2.238	Moderate	6 (5/1)	Ergotamine may increase the atrioventricular blocking (AV block) activities of Propranolol.	#EEA4A4	2.72733471215255	1
Fluvoxamine	Tramadol	0.23	2.238	Major	36 (30/6)	Fluvoxamine may increase the neuroexcitatory activities of Tramadol.	#EEA4A4	16.3640082729153	1
Cyclosporine	Omeprazole	0.28	1.194	Moderate	22 (16/6)	The serum concentration of Cyclosporine can be increased when it is combined with Omeprazole.	#F7B9B9	10.0002272778927	1
Warfarin	Methimazole	0.337	2.686	Moderate	14 (12/2)	Methimazole may decrease the anticoagulant activities of Warfarin.	#EA9B9B	6.36378099502261	1
Bisoprolol	Verapamil	0.198	1.722	Major	63 (50/13)	The metabolism of Bisoprolol can be decreased when combined with Verapamil.	#F2AEAE	28.6370144776018	1
Nabumetone	Alendronic acid	0.314	3.357	Moderate	17 (15/2)	The risk or severity of adverse effects can be increased when Nabumetone is combined with Alendronic acid.	#E48E8E	7.72744835109889	1
Enalapril	Tizanidine	0.098	1.045	Major	40 (28/12)	The risk or severity of hypotension can be increased when Tizanidine is combined with Enalapril.	#F9BCBC	18.1822314143503	1
Moxifloxacin	Iron	0.219	1.467	Moderate	77 (59/18)		#F5B4B4	35.0007954726244	1
Fluconazole	Diazepam	0.334	1.791	Moderate	55 (44/11)	The metabolism of Diazepam can be decreased when combined with Fluconazole.	#F2AEAE	25.0005681947317	1
Tramadol	Rasagiline	0.197	1.119	Major	42 (30/12)	Tramadol may increase the neuroexcitatory activities of Rasagiline.	#F8BABA	19.0913429850678	1
Indomethacin	Bisoprolol	0.146	-1.352	Moderate	61 (38/23)	Indomethacin may decrease the antihypertensive activities of Bisoprolol.	#AECDE3	27.7279029068842	1
Galantamine	Solifenacin	0.371	-1.596	Moderate	24 (14/10)	The therapeutic efficacy of Solifenacin can be decreased when used in combination with Galantamine.	#A9C9E1	10.9093388486102	1
Theophylline	Ciprofloxacin	0.274	-2.172	Major	71 (36/35)		#9FC1DD	32.2734607604718	1
Alprazolam	Josamycin	0.111	7.163	None	17 (16/1)	The serum concentration of Alprazolam can be increased when it is combined with Josamycin.	#C24242	7.72744835109889	1
Warfarin	Paroxetine	0.287	1.343	Moderate	32 (24/8)	Paroxetine may increase the anticoagulant activities of Warfarin.	#F6B6B6	14.5457851314803	1
Theophylline	Pentoxifylline	0.431	-1.755	Moderate	25 (14/11)	The serum concentration of Theophylline can be increased when it is combined with Pentoxifylline.	#A6C7E0	11.363894633969	1
Trazodone	Itraconazole	0.134	2.238	Moderate	36 (30/6)	The metabolism of Trazodone can be decreased when combined with Itraconazole.	#EEA4A4	16.3640082729153	1
Indomethacin	Losartan	0.211	1.119	Moderate	49 (35/14)	The metabolism of Indomethacin can be decreased when combined with Losartan.	#F8BABA	22.2732334825792	1
Prednisone	Phenobarbital	0.163	-2.234	Moderate	40 (20/20)	The serum concentration of Prednisone can be decreased when it is combined with Phenobarbital.	#9DC0DC	18.1822314143503	1
Gentamicin	Cefonicid	0.784	2.462	Moderate	13 (11/2)		#EC9F9F	5.90922520966386	1
Duloxetine	Nortriptyline	0.576	-1.489	Major	5 (3/2)	Duloxetine may increase the serotonergic activities of Nortriptyline.	#ABCBE2	2.27277892679379	1
Propranolol	Glipizide	0.192	3.581	Moderate	9 (8/1)	Propranolol may increase the hypoglycemic activities of Glipizide.	#E28989	4.09100206822882	1
Imipramine	Epinephrine	0.048	Inf	Major	1 (1/0)	Imipramine may decrease the antihypertensive activities of Epinephrine.	#B32020	0.454555785358758	1
Fluconazole	Tolterodine	0.142	2.238	Moderate	24 (20/4)	The metabolism of Tolterodine can be decreased when combined with Fluconazole.	#EEA4A4	10.9093388486102	1
Erythromycin	Acenocoumarol	0.106	1.311	None	55 (41/14)	The serum concentration of Acenocoumarol can be increased when it is combined with Erythromycin.	#F7B7B7	25.0005681947317	1
Theophylline	Clarithromycin	0.337	-1.436	Moderate	23 (14/9)	The metabolism of Theophylline can be decreased when combined with Clarithromycin.	#ACCCE3	10.4547830632514	1
Amitriptyline	Clonidine	0.333	Inf	Major	1 (1/0)	Amitriptyline may decrease the antihypertensive activities of Clonidine.	#B32020	0.454555785358758	1
Pravastatin	Gemfibrozil	0.3	-1.051	Major	25 (17/8)	The risk or severity of rhabdomyolysis. myoglobinuria. and elevated creatine kinase (CPK) can be increased when Gemfibrozil is combined with Pravastatin.	#B4D1E6	11.363894633969	1
Bisoprolol	Insulin glulisine	0.246	-1.051	Moderate	25 (17/8)		#B4D1E6	11.363894633969	1
Ibandronate	Iron	0.37	2.35	Moderate	25 (21/4)		#EDA1A1	11.363894633969	1
Diltiazem	Midazolam	0.327	1.007	Moderate	26 (18/8)	The metabolism of Midazolam can be decreased when combined with Diltiazem.	#F9BCBC	11.8184504193277	1
Citalopram	Metoprolol	0.45	1.119	Moderate	21 (15/6)	The serum concentration of Metoprolol can be increased when it is combined with Citalopram.	#F8BABA	9.54567149253392	1
Dihydroergotamine	Almotriptan	0.524	-2.234	Major	2 (1/1)	Dihydroergotamine may increase the vasoconstricting activities of Almotriptan.	#9DC0DC	0.909111570717516	1
Atenolol	Insulin detemir	0.324	-1.068	Moderate	34 (23/11)		#B4D1E6	15.4548967021978	1
Fluvoxamine	Acenocoumarol	0.312	1.716	None	29 (23/6)	The metabolism of Acenocoumarol can be decreased when combined with Fluvoxamine.	#F2AEAE	13.182117775404	1
Amitriptyline	Donepezil	0.359	2.686	Moderate	28 (24/4)		#EA9B9B	12.7275619900452	1
Lansoprazole	Itraconazole	0.193	2.388	Moderate	19 (16/3)	The serum concentration of Itraconazole can be decreased when it is combined with Lansoprazole.	#EDA1A1	8.6365599218164	1
Enalapril	Rifampicin	0.143	-1.489	None	40 (24/16)	The metabolism of Enalapril can be increased when combined with Rifampicin.	#ABCBE2	18.1822314143503	1
Galantamine	Methotrimeprazine	0.342	1.679	Moderate	19 (15/4)	The metabolism of Galantamine can be decreased when combined with Methotrimeprazine.	#F3AFAF	8.6365599218164	1
Phenytoin	Topiramate	0.513	-1.489	Moderate	5 (3/2)	The serum concentration of Phenytoin can be increased when it is combined with Topiramate.	#ABCBE2	2.27277892679379	1
Celecoxib	Acenocoumarol	0.139	-1.188	None	72 (47/25)	Celecoxib may increase the anticoagulant activities of Acenocoumarol.	#B1CFE5	32.7280165458306	1
Trospium	Quetiapine	0.241	-1.183	Moderate	26 (17/9)		#B1CFE5	11.8184504193277	1
Phenobarbital	Acenocoumarol	0.405	-1.737	None	32 (18/14)	The metabolism of Acenocoumarol can be increased when combined with Phenobarbital.	#A6C7E0	14.5457851314803	1
Donepezil	Pipotiazine	0.05	Inf	None	1 (1/0)		#B32020	0.454555785358758	1
Phenytoin	Levodopa	0.46	-2.048	Moderate	23 (12/11)	The therapeutic efficacy of Levodopa can be decreased when used in combination with Phenytoin.	#A0C3DD	10.4547830632514	1
Citalopram	Selegiline	0.331	1.791	Major	15 (12/3)	The risk or severity of adverse effects can be increased when Citalopram is combined with Selegiline.	#F2AEAE	6.81833678038137	1
Propranolol	Repaglinide	0.299	-1.117	Moderate	33 (22/11)		#B2D0E5	15.000340916839	1
Azithromycin	Warfarin	0.105	-1.286	Moderate	52 (33/19)	The metabolism of Warfarin can be decreased when combined with Azithromycin.	#AFCEE4	23.6369008386554	1
Acenocoumarol	Cholestyramine	0.212	1.063	None	27 (19/8)	Cholestyramine can cause a decrease in the absorption of Acenocoumarol resulting in a reduced serum concentration and potentially a decrease in efficacy.	#F9BCBC	12.2730062046865	1
Indomethacin	Alendronic acid	0.181	9.849	Moderate	23 (22/1)	The risk or severity of adverse effects can be increased when Indomethacin is combined with Alendronic acid.	#B32020	10.4547830632514	1
Simvastatin	Fusidic acid	0.088	1.058	None	37 (26/11)	The serum concentration of Simvastatin can be increased when it is combined with Fusidic Acid.	#F9BCBC	16.8185640582741	1
Spironolactone	Quinapril	0.279	1.063	Major	27 (19/8)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Quinapril.	#F9BCBC	12.2730062046865	1
Valproic acid	Carbamazepine	0.867	2.686	Moderate	7 (6/1)	The serum concentration of the active metabolites of Carbamazepine can be increased when Carbamazepine is used in combination with Valproic Acid.	#EA9B9B	3.18189049751131	1
Propranolol	Propafenone	0.318	Inf	Moderate	8 (8/0)	The serum concentration of Propranolol can be increased when it is combined with Propafenone.	#B32020	3.63644628287007	1
Ropinirole	Ciprofloxacin	0.137	-2.234	Moderate	38 (19/19)	The serum concentration of Ropinirole can be increased when it is combined with Ciprofloxacin.	#9DC0DC	17.2731198436328	1
Levothyroxine	Raloxifene	0.324	7.163	Moderate	17 (16/1)	Raloxifene can cause a decrease in the absorption of Levothyroxine resulting in a reduced serum concentration and potentially a decrease in efficacy.	#C24242	7.72744835109889	1
Fludrocortisone	Acetylsalicylic acid	0.373	-2.578	Moderate	28 (13/15)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Fludrocortisone.	#97BCD9	12.7275619900452	1
Oxycodone	Paroxetine	0.306	4.477	Moderate	22 (20/2)	The metabolism of Oxycodone can be decreased when combined with Paroxetine.	#DA7878	10.0002272778927	1
Fluoxetine	Carbamazepine	0.471	4.477	Moderate	11 (10/1)	The metabolism of Carbamazepine can be decreased when combined with Fluoxetine.	#DA7878	5.00011363894634	1
Glimepiride	Pregabalin	0.204	-1.005	None	29 (20/9)	The risk or severity of heart failure can be increased when Pregabalin is combined with Glimepiride.	#B4D1E6	13.182117775404	1
Pyridostigmine	Methylprednisolone	0.526	1.343	Moderate	8 (6/2)	The risk or severity of adverse effects can be increased when Methylprednisolone is combined with Pyridostigmine.	#F6B6B6	3.63644628287007	1
Amikacin	Cefonicid	0.344	Inf	Moderate	3 (3/0)		#B32020	1.36366735607627	1
Folic acid	Primidone	0.38	-2.234	Moderate	18 (9/9)	The serum concentration of Primidone can be decreased when it is combined with Folic Acid.	#9DC0DC	8.18200413645765	1
Duloxetine	Rasagiline	0.714	2.686	Major	7 (6/1)	Rasagiline may increase the orthostatic hypotensive activities of Duloxetine.	#EA9B9B	3.18189049751131	1
Dihydroergotamine	Fluoxetine	0.155	Inf	Major	5 (5/0)	The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Fluoxetine.	#B32020	2.27277892679379	1
Phenytoin	Clarithromycin	0.062	1.343	Moderate	16 (12/4)	The serum concentration of the active metabolites of Clarithromycin can be increased when Clarithromycin is used in combination with Phenytoin.	#F6B6B6	7.27289256574013	1
Erythromycin	Atorvastatin	0.096	-1.804	Major	47 (26/21)	The serum concentration of Atorvastatin can be increased when it is combined with Erythromycin.	#A5C6DF	21.3641219118616	1
Nabumetone	Acenocoumarol	0.162	-1.117	None	27 (18/9)	Nabumetone may increase the anticoagulant activities of Acenocoumarol.	#B2D0E5	12.2730062046865	1
Doxycycline	Rifampicin	0.55	Inf	Moderate	2 (2/0)	The serum concentration of Doxycycline can be decreased when it is combined with Rifampicin.	#B32020	0.909111570717516	1
Phenytoin	Amiodarone	0.343	-1.675	Moderate	21 (12/9)	The serum concentration of Phenytoin can be increased when it is combined with Amiodarone.	#A8C8E1	9.54567149253392	1
Acenocoumarol	Etoricoxib	0.108	1.151	None	50 (36/14)	Etoricoxib may increase the anticoagulant activities of Acenocoumarol.	#F8BABA	22.7277892679379	1
Torasemide	Gentamicin	0.184	1.017	Major	36 (25/11)	The serum concentration of Gentamicin can be increased when it is combined with Torasemide.	#F9BCBC	16.3640082729153	1
Fluoxetine	Propafenone	0.373	1.194	Moderate	11 (8/3)	Propafenone may increase the QTc-prolonging activities of Fluoxetine.	#F7B9B9	5.00011363894634	1
Metoprolol	Salbutamol	0.171	-1.34	Moderate	24 (15/9)	Metoprolol may decrease the bronchodilatory activities of Salbutamol.	#AECDE3	10.9093388486102	1
Pravastatin	Colchicine	0.205	-4.468	Major	42 (14/28)	Colchicine may increase the myopathic rhabdomyolysis activities of Pravastatin.	#73A0C9	19.0913429850678	1
Doxycycline	Acenocoumarol	0.086	-1.564	None	34 (20/14)	The metabolism of Acenocoumarol can be decreased when combined with Doxycycline.	#A9C9E1	15.4548967021978	1
Methotrexate	Ibuprofen	0.235	1.074	Major	34 (24/10)	The serum concentration of Methotrexate can be increased when it is combined with Ibuprofen.	#F9BCBC	15.4548967021978	1
Phenytoin	Dexamethasone	0.259	1.045	Moderate	10 (7/3)	The serum concentration of Dexamethasone can be decreased when it is combined with Phenytoin.	#F9BCBC	4.54555785358758	1
Propranolol	Rizatriptan	0.358	Inf	Moderate	4 (4/0)	The serum concentration of Rizatriptan can be increased when it is combined with Propranolol.	#B32020	1.81822314143503	1
Doxycycline	Amoxicillin	0.274	-1.241	Moderate	56 (36/20)	The therapeutic efficacy of Amoxicillin can be decreased when used in combination with Doxycycline.	#AFCEE4	25.4551239800905	1
Repaglinide	Nadolol	0.25	Inf	Moderate	3 (3/0)		#B32020	1.36366735607627	1
Repaglinide	Glipizide	0.334	-1.241	None	14 (9/5)	Repaglinide may increase the hypoglycemic activities of Glipizide.	#AFCEE4	6.36378099502261	1
Diltiazem	Propranolol	0.358	1.119	Major	35 (25/10)	The metabolism of Propranolol can be decreased when combined with Diltiazem.	#F8BABA	15.9094524875565	1
Glycopyrronium	Rivastigmine	0.332	-1.675	None	14 (8/6)	The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Rivastigmine.	#A8C8E1	6.36378099502261	1
Spironolactone	Perindopril	0.286	-1.577	Major	29 (17/12)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Perindopril.	#A9C9E1	13.182117775404	1
Prednisolone	Acetylsalicylic acid	0.061	2.388	Moderate	19 (16/3)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Prednisolone.	#EDA1A1	8.6365599218164	1
Sotalol	Levofloxacin	0.106	2.686	Major	14 (12/2)	Levofloxacin may increase the QTc-prolonging activities of Sotalol.	#EA9B9B	6.36378099502261	1
Paroxetine	Propafenone	0.283	1.455	Moderate	17 (13/4)	The serum concentration of Propafenone can be increased when it is combined with Paroxetine.	#F5B4B4	7.72744835109889	1
Propranolol	Terbutaline	0.122	-1.203	Major	20 (13/7)		#B1CFE5	9.09111570717516	1
Amitriptyline	Rivastigmine	0.388	2.126	Moderate	23 (19/4)		#EFA6A6	10.4547830632514	1
Spironolactone	Cholestyramine	0.373	1.074	Moderate	17 (12/5)	The risk or severity of adverse effects can be increased when Cholestyramine is combined with Spironolactone.	#F9BCBC	7.72744835109889	1
Imipramine	Carbamazepine	0.145	Inf	Moderate	2 (2/0)	The metabolism of Imipramine can be increased when combined with Carbamazepine.	#B32020	0.909111570717516	1
Ziprasidone	Chlorpromazine	0.125	Inf	Major	1 (1/0)	Chlorpromazine may increase the QTc-prolonging activities of Ziprasidone.	#B32020	0.454555785358758	1
Verapamil	Primidone	0.208	Inf	Moderate	3 (3/0)	The metabolism of Verapamil can be increased when combined with Primidone.	#B32020	1.36366735607627	1
Spironolactone	Eprosartan	0.307	1.231	Major	30 (22/8)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Eprosartan.	#F7B9B9	13.6366735607627	1
Amitriptyline	Rasagiline	0.42	-2.553	Major	15 (7/8)	Rasagiline may increase the serotonergic activities of Amitriptyline.	#97BCD9	6.81833678038137	1
Digoxin	Methotrexate	0.276	2.388	Moderate	19 (16/3)	Digoxin may decrease the cardiotoxic activities of Methotrexate.	#EDA1A1	8.6365599218164	1
Sertraline	Propafenone	0.416	1.194	Moderate	22 (16/6)	Sertraline may increase the QTc-prolonging activities of Propafenone.	#F7B9B9	10.0002272778927	1
Phenytoin	Megestrol acetate	0.269	1.492	Moderate	13 (10/3)		#F5B2B2	5.90922520966386	1
Zolmitriptan	Ergotamine	0.5	Inf	Major	1 (1/0)	Ergotamine may increase the vasoconstricting activities of Zolmitriptan.	#B32020	0.454555785358758	1
Acetaminophen	Isoniazid	0.215	1.023	Moderate	23 (16/7)	The risk or severity of adverse effects can be increased when Isoniazid is combined with Acetaminophen.	#F9BCBC	10.4547830632514	1
Zolmitriptan	Fluoxetine	0.25	Inf	Major	4 (4/0)	The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Fluoxetine.	#B32020	1.81822314143503	1
Diltiazem	Tacrolimus	0.21	-1.241	Moderate	14 (9/5)	The metabolism of Tacrolimus can be decreased when combined with Diltiazem.	#AFCEE4	6.36378099502261	1
Glipizide	Carvedilol	0.203	-1.117	Moderate	15 (10/5)	Carvedilol may increase the hypoglycemic activities of Glipizide.	#B2D0E5	6.81833678038137	1
Citalopram	Zolmitriptan	0.284	Inf	Major	10 (10/0)	The risk or severity of adverse effects can be increased when Citalopram is combined with Zolmitriptan.	#B32020	4.54555785358758	1
Lidocaine	Propranolol	0.184	-1.042	Moderate	22 (15/7)	The serum concentration of Lidocaine can be increased when it is combined with Propranolol.	#B4D1E6	10.0002272778927	1
Clonazepam	Itraconazole	0.212	2.462	None	13 (11/2)	The metabolism of Clonazepam can be decreased when combined with Itraconazole.	#EC9F9F	5.90922520966386	1
Gliclazide	Glucosamine	0.27	1.268	None	23 (17/6)		#F7B7B7	10.4547830632514	1
Cyproheptadine	Fluoxetine	0.071	Inf	Moderate	2 (2/0)	The therapeutic efficacy of Fluoxetine can be decreased when used in combination with Cyproheptadine.	#B32020	0.909111570717516	1
Trospium	Risperidone	0.315	-1.117	Moderate	21 (14/7)		#B2D0E5	9.54567149253392	1
Fluconazole	Lovastatin	0.051	1.455	Major	17 (13/4)	The serum concentration of Lovastatin can be increased when it is combined with Fluconazole.	#F5B4B4	7.72744835109889	1
Oxycodone	Escitalopram	0.298	3.134	Moderate	16 (14/2)	Oxycodone may increase the serotonergic activities of Escitalopram.	#E69393	7.27289256574013	1
Atenolol	Glipizide	0.387	-1.986	Moderate	17 (9/8)	Atenolol may increase the hypoglycemic activities of Glipizide.	#A2C4DE	7.72744835109889	1
Dihydroergotamine	Atenolol	0.089	Inf	Moderate	6 (6/0)	Dihydroergotamine may increase the atrioventricular blocking (AV block) activities of Atenolol.	#B32020	2.72733471215255	1
Trospium	Solifenacin	0.164	-1.117	Moderate	6 (4/2)	The risk or severity of adverse effects can be increased when Trospium is combined with Solifenacin.	#B2D0E5	2.72733471215255	1
Fluvoxamine	Ropinirole	0.576	Inf	Moderate	2 (2/0)	Fluvoxamine may increase the sedative activities of Ropinirole.	#B32020	0.909111570717516	1
Prednisone	Itraconazole	0.333	1.455	Moderate	34 (26/8)	The serum concentration of Prednisone can be increased when it is combined with Itraconazole.	#F5B4B4	15.4548967021978	1
Propranolol	Hydralazine	0.237	Inf	Minor	12 (12/0)	Hydralazine may increase the hypotensive activities of Propranolol.	#B32020	5.4546694243051	1
Citalopram	Josamycin	0.07	2.91	None	15 (13/2)		#E89696	6.81833678038137	1
Sucralfate	Ciprofloxacin	0.283	1.007	Moderate	39 (27/12)		#F9BCBC	17.7276756289916	1
Dexamethasone	Acenocoumarol	0.15	-1.986	None	68 (36/32)		#A2C4DE	30.9097934043956	1
Sotalol	Ibuprofen	0.25	-1.303	Moderate	19 (12/7)	Ibuprofen may decrease the antihypertensive activities of Sotalol.	#AFCEE4	8.6365599218164	1
Propranolol	Phenobarbital	0.519	1.119	Moderate	7 (5/2)	The metabolism of Propranolol can be increased when combined with Phenobarbital.	#F8BABA	3.18189049751131	1
Sertraline	Cilostazol	0.332	1.641	Moderate	14 (11/3)	The serum concentration of Cilostazol can be increased when it is combined with Sertraline.	#F3AFAF	6.36378099502261	1
Alendronic acid	Flurbiprofen	0.198	Inf	Moderate	4 (4/0)	The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Alendronic acid.	#B32020	1.81822314143503	1
Zolmitriptan	Escitalopram	0.653	Inf	Major	5 (5/0)	The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Escitalopram.	#B32020	2.27277892679379	1
Spironolactone	Eplerenone	0.184	-1.718	Major	23 (13/10)	Eplerenone may increase the hyperkalemic activities of Spironolactone.	#A6C7E0	10.4547830632514	1
Diazepam	Itraconazole	0.385	4.029	Moderate	20 (18/2)	The metabolism of Diazepam can be decreased when combined with Itraconazole.	#DE8080	9.09111570717516	1
Amiodarone	Flecainide	0.258	1.343	Major	16 (12/4)	The serum concentration of Flecainide can be increased when it is combined with Amiodarone.	#F6B6B6	7.27289256574013	1
Itraconazole	Budesonide	0.313	1.03	Major	33 (23/10)	The serum concentration of Budesonide can be increased when it is combined with Itraconazole.	#F9BCBC	15.000340916839	1
Phenytoin	Fludrocortisone	0.058	-2.234	Moderate	2 (1/1)	The serum concentration of Fludrocortisone can be decreased when it is combined with Phenytoin.	#9DC0DC	0.909111570717516	1
Erythromycin	Methylprednisolone	0.518	1.903	Moderate	21 (17/4)	The metabolism of Methylprednisolone can be decreased when combined with Erythromycin.	#F1ABAB	9.54567149253392	1
Pimozide	Escitalopram	0.15	Inf	Major	2 (2/0)	The risk or severity of QTc prolongation can be increased when Pimozide is combined with Escitalopram.	#B32020	0.909111570717516	1
Lidocaine	Atenolol	0.194	1.279	Moderate	27 (20/7)	The serum concentration of Lidocaine can be increased when it is combined with Atenolol.	#F7B7B7	12.2730062046865	1
Chlorpromazine	Propranolol	0.301	Inf	Moderate	5 (5/0)	The metabolism of Propranolol can be decreased when combined with Chlorpromazine.	#B32020	2.27277892679379	1
Atorvastatin	Itraconazole	0.16	-1.183	Major	26 (17/9)	The risk or severity of adverse effects can be increased when Itraconazole is combined with Atorvastatin.	#B1CFE5	11.8184504193277	1
Warfarin	Fenofibrate	0.282	-1.117	Major	9 (6/3)	Fenofibrate may increase the anticoagulant activities of Warfarin.	#B2D0E5	4.09100206822882	1
Erythromycin	Fluoxetine	0.157	1.231	Moderate	15 (11/4)	The metabolism of Fluoxetine can be decreased when combined with Erythromycin.	#F7B9B9	6.81833678038137	1
Chlorpromazine	Levofloxacin	0.379	1.268	Moderate	23 (17/6)	Chlorpromazine may increase the QTc-prolonging activities of Levofloxacin.	#F7B7B7	10.4547830632514	1
Phenytoin	Fluoxetine	0.259	-1.276	Moderate	11 (7/4)	The serum concentration of Phenytoin can be increased when it is combined with Fluoxetine.	#AFCEE4	5.00011363894634	1
Paroxetine	Rizatriptan	0.553	Inf	Major	6 (6/0)	The risk or severity of adverse effects can be increased when Paroxetine is combined with Rizatriptan.	#B32020	2.72733471215255	1
Fentanyl	Rifampicin	0.164	1.343	Major	12 (9/3)	The serum concentration of Fentanyl can be decreased when it is combined with Rifampicin.	#F6B6B6	5.4546694243051	1
Cyclosporine	Allopurinol	0.424	-1.489	Moderate	5 (3/2)		#ABCBE2	2.27277892679379	1
Triamcinolone	Acenocoumarol	0.105	-1.646	None	33 (19/14)		#A8C8E1	15.000340916839	1
Atropine	Galantamine	0.031	-2.234	Moderate	2 (1/1)	The therapeutic efficacy of Atropine can be decreased when used in combination with Galantamine.	#9DC0DC	0.909111570717516	1
Verapamil	Phenobarbital	0.46	-1.117	Moderate	6 (4/2)	The metabolism of Verapamil can be increased when combined with Phenobarbital.	#B2D0E5	2.72733471215255	1
Metoprolol	Primidone	0.424	Inf	Moderate	1 (1/0)	The serum concentration of Metoprolol can be decreased when it is combined with Primidone.	#B32020	0.454555785358758	1
Triazolam	Josamycin	1	Inf	None	1 (1/0)	The serum concentration of Triazolam can be increased when it is combined with Josamycin.	#B32020	0.454555785358758	1
Phenytoin	Nisoldipine	0.167	Inf	Major	1 (1/0)	The metabolism of Nisoldipine can be increased when combined with Phenytoin.	#B32020	0.454555785358758	1
Eplerenone	Clarithromycin	0.132	-1.489	Major	15 (9/6)	The serum concentration of Eplerenone can be increased when it is combined with Clarithromycin.	#ABCBE2	6.81833678038137	1
Ranolazine	Diltiazem	0.56	-1.276	Major	11 (7/4)	The serum concentration of Ranolazine can be increased when it is combined with Diltiazem.	#AFCEE4	5.00011363894634	1
Lovastatin	Clarithromycin	0.051	1.194	Major	22 (16/6)	The serum concentration of Lovastatin can be increased when it is combined with Clarithromycin.	#F7B9B9	10.0002272778927	1
Midazolam	Clarithromycin	0.14	1.791	Moderate	15 (12/3)	The serum concentration of Midazolam can be increased when it is combined with Clarithromycin.	#F2AEAE	6.81833678038137	1
Fluoxetine	Warfarin	0.381	1.492	Moderate	13 (10/3)	The metabolism of Warfarin can be decreased when combined with Fluoxetine.	#F5B2B2	5.90922520966386	1
Zolmitriptan	Dihydroergotamine	0.348	-2.234	Major	2 (1/1)	Dihydroergotamine may increase the vasoconstricting activities of Zolmitriptan.	#9DC0DC	0.909111570717516	1
Primidone	Acenocoumarol	0.285	-2.73	None	20 (9/11)	The metabolism of Acenocoumarol can be increased when combined with Primidone.	#94B9D8	9.09111570717516	1
Venlafaxine	Rasagiline	0.495	-2.234	Major	14 (7/7)	The risk or severity of adverse effects can be increased when Venlafaxine is combined with Rasagiline.	#9DC0DC	6.36378099502261	1
Ranitidine	Itraconazole	0.063	2.089	Moderate	17 (14/3)	The serum concentration of Itraconazole can be decreased when it is combined with Ranitidine.	#F0A7A7	7.72744835109889	1
Paroxetine	Selegiline	0.116	2.686	Major	7 (6/1)	The risk or severity of adverse effects can be increased when Paroxetine is combined with Selegiline.	#EA9B9B	3.18189049751131	1
Gentamicin	Ceftriaxone	0.5	1.791	Moderate	5 (4/1)		#F2AEAE	2.27277892679379	1
Fluconazole	Rifampicin	0.383	-1.117	Major	6 (4/2)	The metabolism of Rifampicin can be decreased when combined with Fluconazole.	#B2D0E5	2.72733471215255	1
Phenytoin	Midazolam	0.204	-1.675	Moderate	7 (4/3)	The serum concentration of Phenytoin can be increased when it is combined with Midazolam.	#A8C8E1	3.18189049751131	1
Ciprofloxacin	Methotrexate	0.164	-1.528	Moderate	32 (19/13)	The serum concentration of Methotrexate can be increased when it is combined with Ciprofloxacin.	#ABCBE2	14.5457851314803	1
Erythromycin	Levofloxacin	0.458	1.087	Moderate	48 (34/14)	Erythromycin may increase the QTc-prolonging activities of Levofloxacin.	#F8BABA	21.8186776972204	1
Fluvoxamine	Theophylline	0.607	Inf	Major	3 (3/0)	The metabolism of Theophylline can be decreased when combined with Fluvoxamine.	#B32020	1.36366735607627	1
Warfarin	Acetylsalicylic acid	0.203	-1.971	Major	96 (51/45)	Acetylsalicylic acid may increase the anticoagulant activities of Warfarin.	#A2C4DE	43.6373553944408	1
Repaglinide	Gemfibrozil	0.274	1.641	Major	14 (11/3)	The serum concentration of Repaglinide can be increased when it is combined with Gemfibrozil.	#F3AFAF	6.36378099502261	1
Rifabutin	Simvastatin	0.057	Inf	None	2 (2/0)	The metabolism of Simvastatin can be increased when combined with Rifabutin.	#B32020	0.909111570717516	1
Ziprasidone	Galantamine	0.889	Inf	Moderate	2 (2/0)	Galantamine may increase the QTc-prolonging activities of Ziprasidone.	#B32020	0.909111570717516	1
Phenytoin	Hydrocortisone	0.128	3.134	Moderate	8 (7/1)	The serum concentration of Hydrocortisone can be decreased when it is combined with Phenytoin.	#E69393	3.63644628287007	1
Trospium	Haloperidol	0.156	-1.015	Moderate	16 (11/5)		#B4D1E6	7.27289256574013	1
Carbamazepine	Oxybutynin	0.401	Inf	None	3 (3/0)	The metabolism of Oxybutynin can be increased when combined with Carbamazepine.	#B32020	1.36366735607627	1
Paroxetine	Rasagiline	0.503	-1.787	Major	18 (10/8)	The risk or severity of adverse effects can be increased when Paroxetine is combined with Rasagiline.	#A6C7E0	8.18200413645765	1
Erythromycin	Diazepam	0.34	9.401	Moderate	22 (21/1)	The metabolism of Diazepam can be decreased when combined with Erythromycin.	#B32020	10.0002272778927	1
Sumatriptan	Paroxetine	0.152	1.791	Major	5 (4/1)	The risk or severity of adverse effects can be increased when Sumatriptan is combined with Paroxetine.	#F2AEAE	2.27277892679379	1
Phenytoin	Methylprednisolone	0.127	-1.34	Moderate	16 (10/6)	The serum concentration of Methylprednisolone can be decreased when it is combined with Phenytoin.	#AECDE3	7.27289256574013	1
Ergotamine	Carvedilol	0.229	1.119	Moderate	7 (5/2)	Ergotamine may increase the atrioventricular blocking (AV block) activities of Carvedilol.	#F8BABA	3.18189049751131	1
Fentanyl	Itraconazole	0.238	4.029	Major	20 (18/2)	The serum concentration of Fentanyl can be increased when it is combined with Itraconazole.	#DE8080	9.09111570717516	1
Warfarin	Pentoxifylline	0.244	-1.718	Moderate	23 (13/10)	Pentoxifylline may increase the anticoagulant activities of Warfarin.	#A6C7E0	10.4547830632514	1
Danazol	Acenocoumarol	0.252	-1.117	None	6 (4/2)	Danazol may increase the anticoagulant activities of Acenocoumarol.	#B2D0E5	2.72733471215255	1
Sucralfate	Levothyroxine	0.171	3.357	Minor	17 (15/2)	The serum concentration of Levothyroxine can be decreased when it is combined with Sucralfate.	#E48E8E	7.72744835109889	1
Hydroxyzine	Galantamine	0.224	-1.276	Moderate	22 (14/8)		#AFCEE4	10.0002272778927	1
Doxycycline	Digoxin	0.138	-1.436	Moderate	23 (14/9)	The metabolism of Digoxin can be decreased when combined with Doxycycline.	#ACCCE3	10.4547830632514	1
Erythromycin	Digoxin	0.176	1.399	Moderate	33 (25/8)	The metabolism of Digoxin can be decreased when combined with Erythromycin.	#F5B4B4	15.000340916839	1
Paroxetine	Almotriptan	0.237	1.791	Major	5 (4/1)	The metabolism of Almotriptan can be decreased when combined with Paroxetine.	#F2AEAE	2.27277892679379	1
Cyclosporine	Simvastatin	0.191	1.119	Major	7 (5/2)	The serum concentration of Simvastatin can be increased when it is combined with Cyclosporine.	#F8BABA	3.18189049751131	1
Erythromycin	Lincomycin	0.167	Inf	Moderate	1 (1/0)	The therapeutic efficacy of Erythromycin can be decreased when used in combination with Lincomycin.	#B32020	0.454555785358758	1
Digoxin	Josamycin	0.143	2.462	None	13 (11/2)	The serum concentration of Digoxin can be increased when it is combined with Josamycin.	#EC9F9F	5.90922520966386	1
Pantoprazole	Itraconazole	0.163	1.433	Moderate	21 (16/5)	The serum concentration of Itraconazole can be decreased when it is combined with Pantoprazole.	#F5B4B4	9.54567149253392	1
Biperiden	Donepezil	0.132	1.791	Moderate	10 (8/2)	The therapeutic efficacy of Biperiden can be decreased when used in combination with Donepezil.	#F2AEAE	4.54555785358758	1
Fluconazole	Clonazepam	0.226	-1.117	None	24 (16/8)	The metabolism of Clonazepam can be decreased when combined with Fluconazole.	#B2D0E5	10.9093388486102	1
Imipramine	Salbutamol	0.175	Inf	Moderate	8 (8/0)	The risk or severity of adverse effects can be increased when Imipramine is combined with Salbutamol.	#B32020	3.63644628287007	1
Digoxin	Itraconazole	0.15	2.126	Major	23 (19/4)	The serum concentration of Digoxin can be increased when it is combined with Itraconazole.	#EFA6A6	10.4547830632514	1
Digoxin	Cholestyramine	0.163	1.343	Moderate	16 (12/4)	Cholestyramine can cause a decrease in the absorption of Digoxin resulting in a reduced serum concentration and potentially a decrease in efficacy.	#F6B6B6	7.27289256574013	1
Lovastatin	Colchicine	0.142	-1.862	Major	11 (6/5)	The serum concentration of Colchicine can be increased when it is combined with Lovastatin.	#A5C6DF	5.00011363894634	1
Diclofenac	Warfarin	0.155	-2.351	Major	39 (19/20)	Diclofenac may increase the anticoagulant activities of Warfarin.	#9ABEDB	17.7276756289916	1
Doxycycline	Carbamazepine	0.061	Inf	Moderate	3 (3/0)	The serum concentration of Doxycycline can be decreased when it is combined with Carbamazepine.	#B32020	1.36366735607627	1
Phenytoin	Felodipine	0.271	Inf	Major	2 (2/0)	The metabolism of Felodipine can be increased when combined with Phenytoin.	#B32020	0.909111570717516	1
Fluvoxamine	Olanzapine	0.479	1.791	Moderate	5 (4/1)	The metabolism of Olanzapine can be decreased when combined with Fluvoxamine.	#F2AEAE	2.27277892679379	1
Terbinafine	Acenocoumarol	0.081	-1.276	None	22 (14/8)		#AFCEE4	10.0002272778927	1
Fluconazole	Amitriptyline	0.075	1.94	Moderate	16 (13/3)	Amitriptyline may increase the QTc-prolonging activities of Fluconazole.	#F1ABAB	7.27289256574013	1
Tacrolimus	Atorvastatin	0.254	-2.73	Moderate	20 (9/11)	The risk or severity of adverse effects can be increased when Tacrolimus is combined with Atorvastatin.	#94B9D8	9.09111570717516	1
Moxifloxacin	Warfarin	0.127	-2.393	Major	29 (14/15)		#9ABEDB	13.182117775404	1
Clemastine	Rivastigmine	0.03	Inf	Moderate	2 (2/0)		#B32020	0.909111570717516	1
Atenolol	Insulin glulisine	0.194	2.238	Moderate	6 (5/1)		#EEA4A4	2.72733471215255	1
Thiethylperazine	Bromocriptine	0.27	-2.234	Moderate	2 (1/1)		#9DC0DC	0.909111570717516	1
Atenolol	Terbutaline	0.186	-1.915	Moderate	26 (14/12)	Atenolol may decrease the bronchodilatory activities of Terbutaline.	#A3C5DF	11.8184504193277	1
Amikacin	Furosemide	0.192	-1.422	Major	18 (11/7)	The serum concentration of Amikacin can be increased when it is combined with Furosemide.	#ACCCE3	8.18200413645765	1
Donepezil	Clomipramine	0.245	Inf	Moderate	7 (7/0)	The metabolism of Donepezil can be decreased when combined with Clomipramine.	#B32020	3.18189049751131	1
Almotriptan	Escitalopram	0.263	Inf	Major	3 (3/0)	The risk or severity of adverse effects can be increased when Almotriptan is combined with Escitalopram.	#B32020	1.36366735607627	1
Gentamicin	Bumetanide	0.143	Inf	Major	1 (1/0)	The serum concentration of Gentamicin can be increased when it is combined with Bumetanide.	#B32020	0.454555785358758	1
Metoprolol	Formoterol	0.249	-3.351	Moderate	15 (6/9)	The metabolism of Formoterol can be decreased when combined with Metoprolol.	#88B0D3	6.81833678038137	1
Haloperidol	Itraconazole	0.263	2.686	Moderate	21 (18/3)	The metabolism of Haloperidol can be decreased when combined with Itraconazole.	#EA9B9B	9.54567149253392	1
Donepezil	Oxybutynin	0.326	2.686	Moderate	7 (6/1)	The therapeutic efficacy of Oxybutynin can be decreased when used in combination with Donepezil.	#EA9B9B	3.18189049751131	1
Tolterodine	Itraconazole	0.082	1.045	Moderate	10 (7/3)	The serum concentration of Tolterodine can be increased when it is combined with Itraconazole.	#F9BCBC	4.54555785358758	1
Phenobarbital	Estriol	0.02	Inf	None	1 (1/0)		#B32020	0.454555785358758	1
Galantamine	Oxybutynin	0.619	-1.675	Moderate	7 (4/3)	The therapeutic efficacy of Oxybutynin can be decreased when used in combination with Galantamine.	#A8C8E1	3.18189049751131	1
Trihexyphenidyl	Haloperidol	0.243	-1.117	Moderate	9 (6/3)		#B2D0E5	4.09100206822882	1
Prednisone	Primidone	0.192	-1.675	Moderate	14 (8/6)	The serum concentration of Prednisone can be decreased when it is combined with Primidone.	#A8C8E1	6.36378099502261	1
Methotrexate	Diclofenac	0.192	2.238	Major	12 (10/2)	The serum concentration of Methotrexate can be increased when it is combined with Diclofenac.	#EEA4A4	5.4546694243051	1
Rizatriptan	Escitalopram	0.219	1.791	Major	5 (4/1)	The risk or severity of adverse effects can be increased when Rizatriptan is combined with Escitalopram.	#F2AEAE	2.27277892679379	1
Warfarin	Hydrocortisone	0.147	4.029	Moderate	10 (9/1)	Hydrocortisone may increase the anticoagulant activities of Warfarin.	#DE8080	4.54555785358758	1
Atorvastatin	Josamycin	0.17	1.791	None	10 (8/2)	The risk or severity of adverse effects can be increased when Josamycin is combined with Atorvastatin.	#F2AEAE	4.54555785358758	1
Spironolactone	Fosinopril	0.175	-1.489	Major	15 (9/6)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Fosinopril.	#ABCBE2	6.81833678038137	1
Bisoprolol	Ergotamine	0.232	1.343	Moderate	12 (9/3)	Ergotamine may increase the atrioventricular blocking (AV block) activities of Bisoprolol.	#F6B6B6	5.4546694243051	1
Erythromycin	Amiodarone	0.194	-1.031	Major	19 (13/6)	Erythromycin may increase the QTc-prolonging activities of Amiodarone.	#B4D1E6	8.6365599218164	1
Indomethacin	Carvedilol	0.216	-2.437	Moderate	23 (11/12)	Indomethacin may decrease the antihypertensive activities of Carvedilol.	#99BDDA	10.4547830632514	1
Trihexyphenidyl	Donepezil	0.451	Inf	Moderate	3 (3/0)	The therapeutic efficacy of Trihexyphenidyl can be decreased when used in combination with Donepezil.	#B32020	1.36366735607627	1
Zolmitriptan	Paroxetine	0.38	1.119	Major	7 (5/2)	The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Paroxetine.	#F8BABA	3.18189049751131	1
Alprazolam	Ketoconazole	0.065	1.343	Major	8 (6/2)	The serum concentration of Alprazolam can be increased when it is combined with Ketoconazole.	#F6B6B6	3.63644628287007	1
Fluvoxamine	Amitriptyline	0.193	1.119	Major	7 (5/2)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Amitriptyline.	#F8BABA	3.18189049751131	1
Eplerenone	Tolevamer	0.356	Inf	None	3 (3/0)		#B32020	1.36366735607627	1
Diltiazem	Rifampicin	0.052	Inf	Major	5 (5/0)	The serum concentration of Diltiazem can be decreased when it is combined with Rifampicin.	#B32020	2.27277892679379	1
Selegiline	Escitalopram	0.499	1.791	Major	5 (4/1)	The risk or severity of adverse effects can be increased when Escitalopram is combined with Selegiline.	#F2AEAE	2.27277892679379	1
Losartan	Rifampicin	0.208	2.014	Moderate	11 (9/2)	The serum concentration of Losartan can be decreased when it is combined with Rifampicin.	#F0A9A9	5.00011363894634	1
Hydrochlorothiazide	Lithium cation	0.175	2.686	Major	7 (6/1)	Hydrochlorothiazide may decrease the excretion rate of Lithium which could result in a higher serum level.	#EA9B9B	3.18189049751131	1
Indomethacin	Acenocoumarol	0.195	-1.675	None	35 (20/15)	Indomethacin may increase the anticoagulant activities of Acenocoumarol.	#A8C8E1	15.9094524875565	1
Carvedilol	Insulin glulisine	0.28	-1.34	Moderate	8 (5/3)		#AECDE3	3.63644628287007	1
Fluoxetine	Rasagiline	0.423	-1.787	Major	9 (5/4)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Rasagiline.	#A6C7E0	4.09100206822882	1
Ibuprofen	Lithium cation	0.207	1.343	Moderate	8 (6/2)	The serum concentration of Lithium can be increased when it is combined with Ibuprofen.	#F6B6B6	3.63644628287007	1
Warfarin	Norfloxacin	0.134	1.612	Major	23 (18/5)	Norfloxacin may increase the anticoagulant activities of Warfarin.	#F4B1B1	10.4547830632514	1
Imipramine	Terbutaline	0.117	-1.117	Moderate	3 (2/1)	The risk or severity of adverse effects can be increased when Imipramine is combined with Terbutaline.	#B2D0E5	1.36366735607627	1
Moxifloxacin	Ziprasidone	0.073	Inf	Major	3 (3/0)	Moxifloxacin may increase the QTc-prolonging activities of Ziprasidone.	#B32020	1.36366735607627	1
Glimepiride	Glucosamine	0.326	-1.117	None	9 (6/3)		#B2D0E5	4.09100206822882	1
Rivastigmine	Oxybutynin	0.265	1.119	Moderate	7 (5/2)	The therapeutic efficacy of Oxybutynin can be decreased when used in combination with Rivastigmine.	#F8BABA	3.18189049751131	1
Amitriptyline	Terbutaline	0.227	Inf	Moderate	9 (9/0)	The risk or severity of adverse effects can be increased when Amitriptyline is combined with Terbutaline.	#B32020	4.09100206822882	1
Digoxin	Hydroxychloroquine	0.233	1.045	Moderate	10 (7/3)	The serum concentration of Digoxin can be increased when it is combined with Hydroxychloroquine.	#F9BCBC	4.54555785358758	1
Imipramine	Pseudoephedrine	0.2	Inf	None	1 (1/0)	Imipramine may decrease the antihypertensive activities of Pseudoephedrine.	#B32020	0.454555785358758	1
Levofloxacin	Josamycin	0.478	1.343	None	16 (12/4)		#F6B6B6	7.27289256574013	1
Hydrocortisone	Phenobarbital	0.434	-1.117	Moderate	6 (4/2)	The serum concentration of Hydrocortisone can be decreased when it is combined with Phenobarbital.	#B2D0E5	2.72733471215255	1
Ranolazine	Amiodarone	0.278	-3.127	Major	12 (5/7)	The serum concentration of Ranolazine can be increased when it is combined with Amiodarone.	#8CB4D5	5.4546694243051	1
Pseudoephedrine	Rasagiline	0.162	Inf	Moderate	2 (2/0)	Rasagiline may increase the hypertensive activities of Pseudoephedrine.	#B32020	0.909111570717516	1
Metoprolol	Gliclazide	0.287	1.119	None	7 (5/2)	Metoprolol may increase the hypoglycemic activities of Gliclazide.	#F8BABA	3.18189049751131	1
Carbamazepine	Felodipine	0.26	Inf	Moderate	2 (2/0)	The metabolism of Felodipine can be increased when combined with Carbamazepine.	#B32020	0.909111570717516	1
Sotalol	Repaglinide	0.551	1.343	Moderate	4 (3/1)		#F6B6B6	1.81822314143503	1
Levothyroxine	Cholestyramine	0.275	1.343	Moderate	12 (9/3)	The serum concentration of Levothyroxine can be decreased when it is combined with Cholestyramine.	#F6B6B6	5.4546694243051	1
Lovastatin	Fenofibrate	0.479	Inf	Major	5 (5/0)	The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibrate is combined with Lovastatin.	#B32020	2.27277892679379	1
Propranolol	Maprotiline	0.312	1.343	Minor	4 (3/1)		#F6B6B6	1.81822314143503	1
Fluvoxamine	Imipramine	0.75	Inf	Major	1 (1/0)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Imipramine.	#B32020	0.454555785358758	1
Cimetidine	Nifedipine	0.406	Inf	Moderate	1 (1/0)	The serum concentration of Nifedipine can be increased when it is combined with Cimetidine.	#B32020	0.454555785358758	1
Citalopram	Naratriptan	0.125	Inf	Major	1 (1/0)	The risk or severity of adverse effects can be increased when Citalopram is combined with Naratriptan.	#B32020	0.454555785358758	1
Colestipol	Ursodeoxycholic acid	0.348	Inf	None	1 (1/0)	The serum concentration of Ursodeoxycholic acid can be decreased when it is combined with Colestipol.	#B32020	0.454555785358758	1
Ciprofloxacin	Tizanidine	0.177	-1.218	Major	17 (11/6)	Tizanidine may increase the QTc-prolonging activities of Ciprofloxacin.	#B1CFE5	7.72744835109889	1
Lovastatin	Itraconazole	0.055	2.238	Major	6 (5/1)	The serum concentration of Lovastatin can be increased when it is combined with Itraconazole.	#EEA4A4	2.72733471215255	1
Indomethacin	Atenolol	0.178	-1.737	Moderate	16 (9/7)	Indomethacin may decrease the antihypertensive activities of Atenolol.	#A6C7E0	7.27289256574013	1
Galantamine	Clomipramine	0.138	1.791	Moderate	5 (4/1)	The metabolism of Galantamine can be decreased when combined with Clomipramine.	#F2AEAE	2.27277892679379	1
Erythromycin	Repaglinide	0.148	1.119	Moderate	14 (10/4)	The serum concentration of Repaglinide can be increased when it is combined with Erythromycin.	#F8BABA	6.36378099502261	1
Raloxifene	Estriol	0.75	-2.234	None	2 (1/1)		#9DC0DC	0.909111570717516	1
Biperiden	Rivastigmine	0.237	Inf	Moderate	6 (6/0)	The therapeutic efficacy of Biperiden can be decreased when used in combination with Rivastigmine.	#B32020	2.72733471215255	1
Meloxicam	Acenocoumarol	0.141	1.087	None	24 (17/7)	Meloxicam may increase the anticoagulant activities of Acenocoumarol.	#F8BABA	10.9093388486102	1
Glimepiride	Gemfibrozil	0.185	-2.681	Moderate	11 (5/6)	The metabolism of Glimepiride can be decreased when combined with Gemfibrozil.	#94B9D8	5.00011363894634	1
Fluvoxamine	Clomipramine	0.614	Inf	Major	2 (2/0)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Clomipramine.	#B32020	0.909111570717516	1
Propranolol	Verapamil	0.302	1.194	Major	11 (8/3)	The metabolism of Propranolol can be decreased when combined with Verapamil.	#F7B9B9	5.00011363894634	1
Fluoxetine	Oxycodone	0.202	Inf	Moderate	7 (7/0)	The metabolism of Oxycodone can be decreased when combined with Fluoxetine.	#B32020	3.18189049751131	1
Clarithromycin	Solifenacin	0.178	-2.606	Major	26 (12/14)	The metabolism of Solifenacin can be decreased when combined with Clarithromycin.	#96BBD9	11.8184504193277	1
Fluoxetine	Nortriptyline	0.175	Inf	Major	2 (2/0)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Nortriptyline.	#B32020	0.909111570717516	1
Fenofibrate	Fluvastatin	0.526	1.343	Major	4 (3/1)	The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibrate is combined with Fluvastatin.	#F6B6B6	1.81822314143503	1
Clomipramine	Rasagiline	0.903	Inf	Major	2 (2/0)	Rasagiline may increase the serotonergic activities of Clomipramine.	#B32020	0.909111570717516	1
Trospium	Ipratropium	0.173	-1.625	Moderate	19 (11/8)	The risk or severity of adverse effects can be increased when Ipratropium bromide is combined with Trospium.	#A9C9E1	8.6365599218164	1
Rifampicin	Amiodarone	0.253	1.791	Major	5 (4/1)	The serum concentration of Amiodarone can be decreased when it is combined with Rifampicin.	#F2AEAE	2.27277892679379	1
Estradiol	Ursodeoxycholic acid	0.231	-2.234	None	2 (1/1)	The therapeutic efficacy of Ursodeoxycholic acid can be decreased when used in combination with Estradiol.	#9DC0DC	0.909111570717516	1
Phenobarbital	Dexamethasone	0.331	1.343	Moderate	4 (3/1)	The serum concentration of Dexamethasone can be decreased when it is combined with Phenobarbital.	#F6B6B6	1.81822314143503	1
Erythromycin	Moxifloxacin	0.797	1.343	Major	16 (12/4)	Erythromycin may increase the QTc-prolonging activities of Moxifloxacin.	#F6B6B6	7.27289256574013	1
Cefotaxime	Gentamicin	0.333	Inf	Moderate	1 (1/0)		#B32020	0.454555785358758	1
Methylphenidate	Rasagiline	0.201	-4.468	Moderate	3 (1/2)	Rasagiline may increase the hypertensive activities of Methylphenidate.	#73A0C9	1.36366735607627	1
Cimetidine	Diazepam	0.074	Inf	Moderate	2 (2/0)	The metabolism of Diazepam can be decreased when combined with Cimetidine.	#B32020	0.909111570717516	1
Carbamazepine	Warfarin	0.365	Inf	Moderate	4 (4/0)	The serum concentration of Warfarin can be decreased when it is combined with Carbamazepine.	#B32020	1.81822314143503	1
Atenolol	Verapamil	0.246	2.462	Major	13 (11/2)	Verapamil may increase the hypotensive activities of Atenolol.	#EC9F9F	5.90922520966386	1
Trospium	Hydroxyzine	0.22	-1.117	Moderate	6 (4/2)		#B2D0E5	2.72733471215255	1
Atenolol	Chlorpropamide	0.5	Inf	Moderate	1 (1/0)	Atenolol may increase the hypoglycemic activities of Chlorpropamide.	#B32020	0.454555785358758	1
Trospium	Donepezil	0.39	-1.117	Moderate	6 (4/2)	The therapeutic efficacy of Trospium can be decreased when used in combination with Donepezil.	#B2D0E5	2.72733471215255	1
Phenytoin	Doxycycline	0.039	Inf	Moderate	2 (2/0)	The serum concentration of Doxycycline can be decreased when it is combined with Phenytoin.	#B32020	0.909111570717516	1
Metoprolol	Fluoxetine	0.493	1.343	Moderate	4 (3/1)	The serum concentration of Metoprolol can be increased when it is combined with Fluoxetine.	#F6B6B6	1.81822314143503	1
Ketoconazole	Quetiapine	0.107	2.686	Major	7 (6/1)	The serum concentration of Quetiapine can be increased when it is combined with Ketoconazole.	#EA9B9B	3.18189049751131	1
Atenolol	Insulin aspart	0.282	1.231	Moderate	15 (11/4)		#F7B9B9	6.81833678038137	1
Haloperidol	Atropine	0.185	Inf	Moderate	2 (2/0)		#B32020	0.909111570717516	1
Digoxin	Cyclophosphamide	0.299	1.791	Moderate	5 (4/1)	Digoxin may decrease the cardiotoxic activities of Cyclophosphamide.	#F2AEAE	2.27277892679379	1
Eprosartan	Lithium cation	0.2	Inf	Moderate	1 (1/0)	The serum concentration of Lithium can be increased when it is combined with Eprosartan.	#B32020	0.454555785358758	1
Venlafaxine	Almotriptan	0.508	Inf	Major	2 (2/0)	The risk or severity of adverse effects can be increased when Venlafaxine is combined with Almotriptan.	#B32020	0.909111570717516	1
Atorvastatin	Fusidic acid	0.109	1.791	None	10 (8/2)	The serum concentration of Atorvastatin can be increased when it is combined with Fusidic Acid.	#F2AEAE	4.54555785358758	1
Simvastatin	Rifampicin	0.166	-1.489	Major	15 (9/6)	The metabolism of Simvastatin can be increased when combined with Rifampicin.	#ABCBE2	6.81833678038137	1
Fluconazole	Midazolam	0.483	-2.234	Major	12 (6/6)	The metabolism of Midazolam can be decreased when combined with Fluconazole.	#9DC0DC	5.4546694243051	1
Tobramycin	Furosemide	0.068	-1.564	Major	17 (10/7)	The serum concentration of Tobramycin can be increased when it is combined with Furosemide.	#A9C9E1	7.72744835109889	1
Citalopram	Rizatriptan	0.135	2.686	Major	7 (6/1)	The risk or severity of adverse effects can be increased when Citalopram is combined with Rizatriptan.	#EA9B9B	3.18189049751131	1
Gemfibrozil	Ursodeoxycholic acid	0.184	-1.675	None	7 (4/3)	The therapeutic efficacy of Ursodeoxycholic acid can be decreased when used in combination with Gemfibrozil.	#A8C8E1	3.18189049751131	1
Dextromethorphan	Rasagiline	0.114	1.343	Major	8 (6/2)	Rasagiline may increase the serotonergic activities of Dextromethorphan.	#F6B6B6	3.63644628287007	1
Salbutamol	Doxepin	0.562	Inf	Moderate	3 (3/0)	The risk or severity of adverse effects can be increased when Doxepin is combined with Salbutamol.	#B32020	1.36366735607627	1
Methylprednisolone	Phenobarbital	0.317	-1.34	Moderate	8 (5/3)	The serum concentration of Methylprednisolone can be decreased when it is combined with Phenobarbital.	#AECDE3	3.63644628287007	1
Ramipril	Tizanidine	0.333	1.791	Major	5 (4/1)	The risk or severity of hypotension can be increased when Tizanidine is combined with Ramipril.	#F2AEAE	2.27277892679379	1
Piroxicam	Propranolol	0.183	Inf	Moderate	2 (2/0)	Piroxicam may decrease the antihypertensive activities of Propranolol.	#B32020	0.909111570717516	1
Carbamazepine	Metronidazole	0.356	-1.117	Moderate	6 (4/2)	The metabolism of Metronidazole can be increased when combined with Carbamazepine.	#B2D0E5	2.72733471215255	1
Triamcinolone	Primidone	0.375	Inf	Moderate	1 (1/0)	The metabolism of Triamcinolone can be increased when combined with Primidone.	#B32020	0.454555785358758	1
Imipramine	Fluoxetine	0.379	Inf	Major	2 (2/0)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Imipramine.	#B32020	0.909111570717516	1
Itraconazole	Acenocoumarol	0.104	-2.085	None	29 (15/14)	The serum concentration of Acenocoumarol can be increased when it is combined with Itraconazole.	#A0C3DD	13.182117775404	1
Warfarin	Metronidazole	0.359	1.119	Major	7 (5/2)	The serum concentration of Warfarin can be increased when it is combined with Metronidazole.	#F8BABA	3.18189049751131	1
Warfarin	Propafenone	0.115	Inf	Moderate	3 (3/0)	The serum concentration of Warfarin can be increased when it is combined with Propafenone.	#B32020	1.36366735607627	1
Sotalol	Gliclazide	0.343	-1.489	None	5 (3/2)	Sotalol may increase the hypoglycemic activities of Gliclazide.	#ABCBE2	2.27277892679379	1
Nortriptyline	Salbutamol	0.262	2.238	Moderate	6 (5/1)	The risk or severity of adverse effects can be increased when Nortriptyline is combined with Salbutamol.	#EEA4A4	2.72733471215255	1
Theophylline	Sotalol	0.167	Inf	Major	1 (1/0)	Sotalol may decrease the bronchodilatory activities of Theophylline.	#B32020	0.454555785358758	1
Megestrol acetate	Phenobarbital	0.299	1.791	Moderate	5 (4/1)		#F2AEAE	2.27277892679379	1
Warfarin	Gemfibrozil	0.268	-1.117	Major	6 (4/2)	The metabolism of Warfarin can be decreased when combined with Gemfibrozil.	#B2D0E5	2.72733471215255	1
Fluoxetine	Josamycin	0.422	Inf	None	3 (3/0)		#B32020	1.36366735607627	1
Fosinopril	Tizanidine	0.083	Inf	Major	1 (1/0)	The risk or severity of hypotension can be increased when Tizanidine is combined with Fosinopril.	#B32020	0.454555785358758	1
Maprotiline	Rivastigmine	0.377	Inf	Moderate	3 (3/0)		#B32020	1.36366735607627	1
Warfarin	Cloxacillin	0.067	-1.117	Moderate	12 (8/4)	Cloxacillin may decrease the anticoagulant activities of Warfarin.	#B2D0E5	5.4546694243051	1
Cyclophosphamide	Acenocoumarol	0.155	Inf	None	4 (4/0)		#B32020	1.81822314143503	1
Enalapril	Lithium cation	0.392	1.343	Moderate	8 (6/2)	The serum concentration of Lithium can be increased when it is combined with Enalapril.	#F6B6B6	3.63644628287007	1
Ibuprofen	Oxprenolol	0.045	1.343	None	4 (3/1)	Ibuprofen may decrease the antihypertensive activities of Oxprenolol.	#F6B6B6	1.81822314143503	1
Dihydroergotamine	Isosorbide mononitrate	0.391	1.343	Moderate	4 (3/1)	The metabolism of Isosorbide Mononitrate can be decreased when combined with Dihydroergotamine.	#F6B6B6	1.81822314143503	1
Carbamazepine	Clarithromycin	0.081	1.567	Major	9 (7/2)	The serum concentration of the active metabolites of Clarithromycin can be increased when Clarithromycin is used in combination with Carbamazepine.	#F4B1B1	4.09100206822882	1
Theophylline	Norfloxacin	0.101	1.119	Moderate	14 (10/4)	The metabolism of Theophylline can be decreased when combined with Norfloxacin.	#F8BABA	6.36378099502261	1
Fluoxetine	Cilostazol	0.251	Inf	Moderate	3 (3/0)	The serum concentration of Cilostazol can be increased when it is combined with Fluoxetine.	#B32020	1.36366735607627	1
Sucralfate	Norfloxacin	0.184	2.238	Moderate	12 (10/2)	The serum concentration of Norfloxacin can be decreased when it is combined with Sucralfate.	#EEA4A4	5.4546694243051	1
Pyridostigmine	Hydrocortisone	0.619	-1.117	Moderate	3 (2/1)	The risk or severity of adverse effects can be increased when Hydrocortisone is combined with Pyridostigmine.	#B2D0E5	1.36366735607627	1
Minocycline	Amoxicillin	0.299	1.492	Moderate	13 (10/3)	The therapeutic efficacy of Amoxicillin can be decreased when used in combination with Minocycline.	#F5B2B2	5.90922520966386	1
Theophylline	Primidone	0.429	Inf	Moderate	1 (1/0)	The metabolism of Theophylline can be increased when combined with Primidone.	#B32020	0.454555785358758	1
Galantamine	Perphenazine	0.029	Inf	Moderate	1 (1/0)		#B32020	0.454555785358758	1
Telithromycin	Atorvastatin	0.199	Inf	Major	2 (2/0)	The risk or severity of adverse effects can be increased when Telithromycin is combined with Atorvastatin.	#B32020	0.909111570717516	1
Rifampicin	Dexamethasone	0.425	Inf	Moderate	2 (2/0)	The serum concentration of Dexamethasone can be decreased when it is combined with Rifampicin.	#B32020	0.909111570717516	1
Sotalol	Glyburide	0.087	Inf	Moderate	2 (2/0)	Sotalol may increase the hypoglycemic activities of Glyburide.	#B32020	0.909111570717516	1
Sumatriptan	Escitalopram	0.06	-1.117	Major	3 (2/1)	The risk or severity of adverse effects can be increased when Sumatriptan is combined with Escitalopram.	#B2D0E5	1.36366735607627	1
Rifabutin	Acenocoumarol	0.056	Inf	None	1 (1/0)	The metabolism of Acenocoumarol can be increased when combined with Rifabutin.	#B32020	0.454555785358758	1
Trospium	Olanzapine	0.136	Inf	Moderate	2 (2/0)		#B32020	0.909111570717516	1
Fluorouracil	Acenocoumarol	0.097	-5.744	None	25 (7/18)	The serum concentration of Acenocoumarol can be increased when it is combined with Fluorouracil.	#5A8EBF	11.363894633969	1
Trospium	Desloratadine	0.554	Inf	None	2 (2/0)	The risk or severity of adverse effects can be increased when Trospium is combined with Desloratadine.	#B32020	0.909111570717516	1
Verapamil	Carvedilol	0.381	-1.34	Major	16 (10/6)	The metabolism of Carvedilol can be decreased when combined with Verapamil.	#AECDE3	7.27289256574013	1
Amitriptyline	Galantamine	0.407	1.567	Moderate	9 (7/2)		#F4B1B1	4.09100206822882	1
Terbutaline	Rasagiline	0.13	-1.489	Moderate	5 (3/2)	The risk or severity of adverse effects can be increased when Rasagiline is combined with Terbutaline.	#ABCBE2	2.27277892679379	1
Itraconazole	Solifenacin	0.057	-1.675	Major	7 (4/3)	The metabolism of Solifenacin can be decreased when combined with Itraconazole.	#A8C8E1	3.18189049751131	1
Theophylline	Propranolol	0.328	1.791	Major	5 (4/1)	The metabolism of Propranolol can be decreased when combined with Theophylline.	#F2AEAE	2.27277892679379	1
Warfarin	Dexamethasone	0.204	-1.787	Moderate	9 (5/4)	Dexamethasone may increase the anticoagulant activities of Warfarin.	#A6C7E0	4.09100206822882	1
Erythromycin	Verapamil	0.12	2.238	Major	6 (5/1)	The metabolism of Verapamil can be decreased when combined with Erythromycin.	#EEA4A4	2.72733471215255	1
Carbamazepine	Ketoconazole	1	Inf	Moderate	1 (1/0)	The metabolism of Ketoconazole can be increased when combined with Carbamazepine.	#B32020	0.454555785358758	1
Doxycycline	Insulin detemir	0.053	Inf	Moderate	3 (3/0)		#B32020	1.36366735607627	1
Simvastatin	Ketoconazole	0.136	-1.117	Major	9 (6/3)	The serum concentration of Simvastatin can be increased when it is combined with Ketoconazole.	#B2D0E5	4.09100206822882	1
Phenytoin	Sucralfate	0.548	-1.117	Moderate	3 (2/1)		#B2D0E5	1.36366735607627	1
Warfarin	Phenobarbital	0.24	-2.234	Major	4 (2/2)	The metabolism of Warfarin can be increased when combined with Phenobarbital.	#9DC0DC	1.81822314143503	1
Rivastigmine	Flavoxate	0.144	-2.234	Moderate	2 (1/1)		#9DC0DC	0.909111570717516	1
Dihydroergotamine	Nitroglycerin	0.218	-1.489	Moderate	10 (6/4)	The bioavailability of Dihydroergotamine can be increased when combined with Nitroglycerin.	#ABCBE2	4.54555785358758	1
Galantamine	Maprotiline	0.686	-1.117	Moderate	3 (2/1)		#B2D0E5	1.36366735607627	1
Alendronic acid	Mefenamic acid	0.231	Inf	Moderate	1 (1/0)	The risk or severity of adverse effects can be increased when Mefenamic acid is combined with Alendronic acid.	#B32020	0.454555785358758	1
Prednisone	Ketoconazole	0.276	2.238	Moderate	6 (5/1)	The serum concentration of Prednisone can be increased when it is combined with Ketoconazole.	#EEA4A4	2.72733471215255	1
Omeprazole	Quazepam	0.094	-1.117	Moderate	6 (4/2)	The metabolism of Quazepam can be decreased when combined with Omeprazole.	#B2D0E5	2.72733471215255	1
Lovastatin	Gemfibrozil	0.116	Inf	Major	4 (4/0)	The risk or severity of rhabdomyolysis. myoglobinuria. and elevated creatine kinase (CPK) can be increased when Gemfibrozil is combined with Lovastatin.	#B32020	1.81822314143503	1
Fluconazole	Phenytoin	0.291	-1.675	Moderate	7 (4/3)	The serum concentration of Phenytoin can be increased when it is combined with Fluconazole.	#A8C8E1	3.18189049751131	1
Trospium	Cetirizine	0.062	-1.675	None	7 (4/3)		#A8C8E1	3.18189049751131	1
Minocycline	Acenocoumarol	0.118	1.119	None	7 (5/2)	Minocycline may increase the anticoagulant activities of Acenocoumarol.	#F8BABA	3.18189049751131	1
Chlorthalidone	Lithium cation	0.25	Inf	Major	1 (1/0)	Chlorthalidone may decrease the excretion rate of Lithium which could result in a higher serum level.	#B32020	0.454555785358758	1
Labetalol	Salbutamol	0.338	Inf	Major	2 (2/0)	Labetalol may decrease the vasoconstricting activities of Salbutamol.	#B32020	0.909111570717516	1
Metoprolol	Sertraline	0.516	2.238	Moderate	6 (5/1)	The serum concentration of Metoprolol can be increased when it is combined with Sertraline.	#EEA4A4	2.72733471215255	1
Atenolol	Prazosin	0.519	Inf	Moderate	1 (1/0)	Atenolol may increase the orthostatic hypotensive activities of Prazosin.	#B32020	0.454555785358758	1
Fenofibrate	Rosuvastatin	0.267	Inf	Major	2 (2/0)	The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibrate is combined with Rosuvastatin.	#B32020	0.909111570717516	1
Hydrocortisone	Cholestyramine	0.812	1.343	Moderate	4 (3/1)	Cholestyramine can cause a decrease in the absorption of Hydrocortisone resulting in a reduced serum concentration and potentially a decrease in efficacy.	#F6B6B6	1.81822314143503	1
Colestipol	Acenocoumarol	0.355	Inf	None	3 (3/0)	Colestipol can cause a decrease in the absorption of Acenocoumarol resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B32020	1.36366735607627	1
Propranolol	Rifampicin	0.333	Inf	Moderate	2 (2/0)	The metabolism of Propranolol can be increased when combined with Rifampicin.	#B32020	0.909111570717516	1
Warfarin	Cholestyramine	0.072	Inf	Moderate	2 (2/0)	Cholestyramine can cause a decrease in the absorption of Warfarin resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B32020	0.909111570717516	1
Isoniazid	Acenocoumarol	0.386	Inf	None	3 (3/0)	The metabolism of Acenocoumarol can be decreased when combined with Isoniazid.	#B32020	1.36366735607627	1
Phenytoin	Rifampicin	0.727	Inf	Major	1 (1/0)	The serum concentration of Phenytoin can be decreased when it is combined with Rifampicin.	#B32020	0.454555785358758	1
Venlafaxine	Propafenone	0.184	-1.675	Moderate	7 (4/3)	The serum concentration of Venlafaxine can be increased when it is combined with Propafenone.	#A8C8E1	3.18189049751131	1
Rosuvastatin	Colchicine	0.144	-2.234	Moderate	4 (2/2)	Colchicine may increase the myopathic rhabdomyolysis activities of Rosuvastatin.	#9DC0DC	1.81822314143503	1
Celecoxib	Lithium cation	0.091	Inf	Major	1 (1/0)	The serum concentration of Lithium can be increased when it is combined with Celecoxib.	#B32020	0.454555785358758	1
Ciprofloxacin	Sevelamer	0.269	-3.127	Moderate	12 (5/7)		#8CB4D5	5.4546694243051	1
Metronidazole	Phenobarbital	0.04	Inf	Moderate	2 (2/0)	The serum concentration of Metronidazole can be decreased when it is combined with Phenobarbital.	#B32020	0.909111570717516	1
Donepezil	Flavoxate	0.045	Inf	Moderate	1 (1/0)		#B32020	0.454555785358758	1
Trospium	Galantamine	0.519	-4.468	Moderate	6 (2/4)	The therapeutic efficacy of Trospium can be decreased when used in combination with Galantamine.	#73A0C9	2.72733471215255	1
Amitriptyline	Rifampicin	0.15	-2.234	Minor	4 (2/2)	The metabolism of Amitriptyline can be increased when combined with Rifampicin.	#9DC0DC	1.81822314143503	1
Rifampicin	Atorvastatin	0.196	-2.234	Major	8 (4/4)	The metabolism of Atorvastatin can be increased when combined with Rifampicin.	#9DC0DC	3.63644628287007	1
Dihydroergotamine	Propranolol	0.149	Inf	Moderate	2 (2/0)	Dihydroergotamine may increase the atrioventricular blocking (AV block) activities of Propranolol.	#B32020	0.909111570717516	1
Ticlopidine	Theophylline	0.071	Inf	Moderate	1 (1/0)	The metabolism of Theophylline can be decreased when combined with Ticlopidine.	#B32020	0.454555785358758	1
Pravastatin	Bezafibrate	0.061	Inf	None	3 (3/0)	Bezafibrate may increase the myopathic rhabdomyolysis activities of Pravastatin.	#B32020	1.36366735607627	1
Bisoprolol	Rifampicin	0.312	-2.606	Moderate	13 (6/7)	The metabolism of Bisoprolol can be increased when combined with Rifampicin.	#96BBD9	5.90922520966386	1
Imipramine	Donepezil	0.28	Inf	Moderate	2 (2/0)	The metabolism of Donepezil can be decreased when combined with Imipramine.	#B32020	0.909111570717516	1
Sucralfate	Levofloxacin	0.364	-1.862	Moderate	22 (12/10)	The serum concentration of Levofloxacin can be decreased when it is combined with Sucralfate.	#A5C6DF	10.0002272778927	1
Warfarin	Ketoprofen	0.042	Inf	Major	1 (1/0)	Ketoprofen may increase the anticoagulant activities of Warfarin.	#B32020	0.454555785358758	1
Chlorpromazine	Rivastigmine	0.321	-1.489	Moderate	5 (3/2)		#ABCBE2	2.27277892679379	1
Alprazolam	Telithromycin	0.026	Inf	Moderate	2 (2/0)	The serum concentration of Alprazolam can be increased when it is combined with Telithromycin.	#B32020	0.909111570717516	1
Warfarin	Itraconazole	0.155	Inf	Moderate	3 (3/0)	The serum concentration of Warfarin can be increased when it is combined with Itraconazole.	#B32020	1.36366735607627	1
Lovastatin	Warfarin	0.288	-1.117	Moderate	6 (4/2)	The metabolism of Warfarin can be decreased when combined with Lovastatin.	#B2D0E5	2.72733471215255	1
Erythromycin	Carbamazepine	0.069	Inf	Major	3 (3/0)	The metabolism of Carbamazepine can be decreased when combined with Erythromycin.	#B32020	1.36366735607627	1
Metoprolol	Salmeterol	0.409	-3.909	Moderate	11 (4/7)	Metoprolol may decrease the bronchodilatory activities of Salmeterol.	#7DA8CE	5.00011363894634	1
Rosuvastatin	Gemfibrozil	0.418	-1.117	Major	3 (2/1)	The risk or severity of rhabdomyolysis. myoglobinuria. and elevated creatine kinase (CPK) can be increased when Gemfibrozil is combined with Rosuvastatin.	#B2D0E5	1.36366735607627	1
Ketoconazole	Atorvastatin	0.166	-2.978	Major	7 (3/4)	The serum concentration of Atorvastatin can be increased when it is combined with Ketoconazole.	#90B6D6	3.18189049751131	1
Thiethylperazine	Levofloxacin	0.385	1.194	None	22 (16/6)		#F7B9B9	10.0002272778927	1
Prednisone	Estradiol	0.683	1.343	Moderate	4 (3/1)	The serum concentration of Prednisone can be increased when it is combined with Estradiol.	#F6B6B6	1.81822314143503	1
Citalopram	Frovatriptan	0.079	-2.234	Major	2 (1/1)	The risk or severity of adverse effects can be increased when Citalopram is combined with Frovatriptan.	#9DC0DC	0.909111570717516	1
Trospium	Clomipramine	0.04	Inf	Moderate	1 (1/0)		#B32020	0.454555785358758	1
Warfarin	Clarithromycin	0.132	-1.596	Major	12 (7/5)	The metabolism of Warfarin can be decreased when combined with Clarithromycin.	#A9C9E1	5.4546694243051	1
Diclofenac	Rifampicin	0.394	Inf	Moderate	4 (4/0)	The serum concentration of Diclofenac can be decreased when it is combined with Rifampicin.	#B32020	1.81822314143503	1
Disopyramide	Omeprazole	0.081	Inf	None	2 (2/0)		#B32020	0.909111570717516	1
Nabumetone	Methotrexate	0.238	-2.234	Major	2 (1/1)	The serum concentration of Methotrexate can be increased when it is combined with Nabumetone.	#9DC0DC	0.909111570717516	1
Spironolactone	Benazepril	0.583	Inf	Major	2 (2/0)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Benazepril.	#B32020	0.909111570717516	1
Digoxin	Sulfasalazine	0.158	-1.117	Moderate	3 (2/1)	The serum concentration of Digoxin can be increased when it is combined with Sulfasalazine.	#B2D0E5	1.36366735607627	1
Diazepam	Ketoconazole	0.5	Inf	Moderate	3 (3/0)	The metabolism of Diazepam can be decreased when combined with Ketoconazole.	#B32020	1.36366735607627	1
Minocycline	Cloxacillin	1	Inf	Moderate	2 (2/0)	The therapeutic efficacy of Cloxacillin can be decreased when used in combination with Minocycline.	#B32020	0.909111570717516	1
Megestrol acetate	Primidone	0.183	Inf	Moderate	2 (2/0)		#B32020	0.909111570717516	1
Erythromycin	Itraconazole	0.778	Inf	Major	3 (3/0)	The metabolism of Erythromycin can be decreased when combined with Itraconazole.	#B32020	1.36366735607627	1
Colestipol	Hydrocortisone	0.071	Inf	Moderate	1 (1/0)	Colestipol can cause a decrease in the absorption of Hydrocortisone resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B32020	0.454555785358758	1
Betamethasone	Acenocoumarol	0.237	-1.117	None	9 (6/3)		#B2D0E5	4.09100206822882	1
Fluconazole	Warfarin	0.228	2.238	Major	6 (5/1)	The serum concentration of Warfarin can be increased when it is combined with Fluconazole.	#EEA4A4	2.72733471215255	1
Fluoxetine	Lithium cation	1	Inf	Major	1 (1/0)	Lithium may increase the serotonergic activities of Fluoxetine.	#B32020	0.454555785358758	1
Perphenazine	Levofloxacin	0.181	1.343	Moderate	4 (3/1)		#F6B6B6	1.81822314143503	1
Citalopram	Sumatriptan	0.068	1.343	Major	4 (3/1)	The risk or severity of adverse effects can be increased when Citalopram is combined with Sumatriptan.	#F6B6B6	1.81822314143503	1
Pantoprazole	Ketoconazole	0.145	-2.978	Moderate	7 (3/4)	The serum concentration of Ketoconazole can be decreased when it is combined with Pantoprazole.	#90B6D6	3.18189049751131	1
Ticlopidine	Carbamazepine	0.243	-2.234	Moderate	2 (1/1)	The metabolism of Ticlopidine can be increased when combined with Carbamazepine.	#9DC0DC	0.909111570717516	1
Oxytetracycline	Amoxicillin	0.5	Inf	Moderate	1 (1/0)		#B32020	0.454555785358758	1
Sucralfate	Ibandronate	0.261	-2.234	Moderate	4 (2/2)		#9DC0DC	1.81822314143503	1
Metoprolol	Lidocaine	0.114	Inf	Moderate	2 (2/0)	The serum concentration of Metoprolol can be increased when it is combined with Lidocaine.	#B32020	0.909111570717516	1
Lansoprazole	Ketoconazole	0.625	Inf	Moderate	2 (2/0)	The serum concentration of Ketoconazole can be decreased when it is combined with Lansoprazole.	#B32020	0.909111570717516	1
Tizanidine	Perindopril	0.008	Inf	Major	1 (1/0)	The risk or severity of hypotension can be increased when Tizanidine is combined with Perindopril.	#B32020	0.454555785358758	1
Citalopram	Almotriptan	0.056	1.343	Major	4 (3/1)	The risk or severity of adverse effects can be increased when Citalopram is combined with Almotriptan.	#F6B6B6	1.81822314143503	1
Phenytoin	Betamethasone	0.072	-2.234	Moderate	2 (1/1)	The serum concentration of Betamethasone can be decreased when it is combined with Phenytoin.	#9DC0DC	0.909111570717516	1
Fluconazole	Eplerenone	0.11	1.343	Moderate	4 (3/1)	The serum concentration of Eplerenone can be increased when it is combined with Fluconazole.	#F6B6B6	1.81822314143503	1
Clonidine	Bisoprolol	0.265	Inf	Major	1 (1/0)	Clonidine may increase the atrioventricular blocking (AV block) activities of Bisoprolol.	#B32020	0.454555785358758	1
Sotalol	Clarithromycin	0.108	-2.234	Major	4 (2/2)	Clarithromycin may increase the QTc-prolonging activities of Sotalol.	#9DC0DC	1.81822314143503	1
Colestipol	Levothyroxine	0.148	Inf	Moderate	2 (2/0)	The serum concentration of Levothyroxine can be decreased when it is combined with Colestipol.	#B32020	0.909111570717516	1
Warfarin	Naproxen	0.064	1.045	Major	10 (7/3)	Naproxen may increase the anticoagulant activities of Warfarin.	#F9BCBC	4.54555785358758	1
Esomeprazole	Itraconazole	0.294	-1.117	Moderate	6 (4/2)	The serum concentration of Itraconazole can be decreased when it is combined with Esomeprazole.	#B2D0E5	2.72733471215255	1
Metoprolol	Diltiazem	0.555	Inf	Major	3 (3/0)	The serum concentration of Metoprolol can be increased when it is combined with Diltiazem.	#B32020	1.36366735607627	1
Telmisartan	Lithium cation	1	Inf	Moderate	1 (1/0)	The serum concentration of Lithium can be increased when it is combined with Telmisartan.	#B32020	0.454555785358758	1
Fluvastatin	Gemfibrozil	0.533	-1.117	Major	3 (2/1)	The risk or severity of rhabdomyolysis. myoglobinuria. and elevated creatine kinase (CPK) can be increased when Gemfibrozil is combined with Fluvastatin.	#B2D0E5	1.36366735607627	1
Tizanidine	Quinapril	0.05	Inf	Major	1 (1/0)	The risk or severity of hypotension can be increased when Tizanidine is combined with Quinapril.	#B32020	0.454555785358758	1
Valsartan	Lithium cation	0.06	Inf	Moderate	2 (2/0)	The serum concentration of Lithium can be increased when it is combined with Valsartan.	#B32020	0.909111570717516	1
Moxifloxacin	Sucralfate	0.326	-1.787	Moderate	9 (5/4)		#A6C7E0	4.09100206822882	1
Rifampicin	Itraconazole	0.5	Inf	Major	1 (1/0)	The serum concentration of Itraconazole can be decreased when it is combined with Rifampicin.	#B32020	0.454555785358758	1
Itraconazole	Aripiprazole	0.048	Inf	Moderate	1 (1/0)	The serum concentration of Aripiprazole can be increased when it is combined with Itraconazole.	#B32020	0.454555785358758	1
Labetalol	Ibuprofen	0.096	Inf	Moderate	2 (2/0)	Ibuprofen may decrease the antihypertensive activities of Labetalol.	#B32020	0.909111570717516	1
Glimepiride	Ketoconazole	0.125	Inf	None	1 (1/0)	The metabolism of Glimepiride can be decreased when combined with Ketoconazole.	#B32020	0.454555785358758	1
Diltiazem	Triazolam	0.299	-1.117	Moderate	3 (2/1)	The metabolism of Triazolam can be decreased when combined with Diltiazem.	#B2D0E5	1.36366735607627	1
Ergotamine	Nitroglycerin	0.181	-1.675	Moderate	7 (4/3)	The bioavailability of Ergotamine can be increased when combined with Nitroglycerin.	#A8C8E1	3.18189049751131	1
Nortriptyline	Galantamine	0.476	Inf	Moderate	1 (1/0)		#B32020	0.454555785358758	1
Midazolam	Rifampicin	0.072	-2.234	Minor	2 (1/1)	The metabolism of Midazolam can be increased when combined with Rifampicin.	#9DC0DC	0.909111570717516	1
Telithromycin	Acenocoumarol	0.029	Inf	None	2 (2/0)	The metabolism of Acenocoumarol can be decreased when combined with Telithromycin.	#B32020	0.909111570717516	1
Doxycycline	Methotrexate	0.053	Inf	Moderate	1 (1/0)		#B32020	0.454555785358758	1
Cyclosporine	Carvedilol	0.667	Inf	Moderate	1 (1/0)	The serum concentration of Cyclosporine can be increased when it is combined with Carvedilol.	#B32020	0.454555785358758	1
Nifedipine	Phenobarbital	0.836	Inf	Major	2 (2/0)	The serum concentration of Nifedipine can be decreased when it is combined with Phenobarbital.	#B32020	0.909111570717516	1
Fluvoxamine	Duloxetine	0.175	Inf	Major	2 (2/0)	The serum concentration of Duloxetine can be increased when it is combined with Fluvoxamine.	#B32020	0.909111570717516	1
Trihexyphenidyl	Galantamine	0.312	-2.234	Moderate	2 (1/1)	The therapeutic efficacy of Trihexyphenidyl can be decreased when used in combination with Galantamine.	#9DC0DC	0.909111570717516	1
Verapamil	Triazolam	0.778	Inf	Moderate	1 (1/0)	The metabolism of Triazolam can be decreased when combined with Verapamil.	#B32020	0.454555785358758	1
Erythromycin	Eplerenone	0.041	-2.234	Moderate	4 (2/2)	The serum concentration of Eplerenone can be increased when it is combined with Erythromycin.	#9DC0DC	1.81822314143503	1
Telithromycin	Amiodarone	0.067	Inf	Major	1 (1/0)	Telithromycin may increase the QTc-prolonging activities of Amiodarone.	#B32020	0.454555785358758	1
Imipramine	Duloxetine	0.048	Inf	Major	1 (1/0)	Duloxetine may increase the serotonergic activities of Imipramine.	#B32020	0.454555785358758	1
Phenytoin	Trimethoprim	0.176	-3.351	Moderate	10 (4/6)	The serum concentration of Phenytoin can be increased when it is combined with Trimethoprim.	#88B0D3	4.54555785358758	1
Metoprolol	Paroxetine	0.151	1.343	Moderate	4 (3/1)	The serum concentration of Metoprolol can be increased when it is combined with Paroxetine.	#F6B6B6	1.81822314143503	1
Tizanidine	Rivastigmine	0.294	-1.117	Moderate	3 (2/1)	Tizanidine may increase the bradycardic activities of Rivastigmine.	#B2D0E5	1.36366735607627	1
Prednisolone	Acenocoumarol	0.059	Inf	None	3 (3/0)		#B32020	1.36366735607627	1
Fluconazole	Cyclophosphamide	0.091	Inf	None	1 (1/0)	The metabolism of Cyclophosphamide can be decreased when combined with Fluconazole.	#B32020	0.454555785358758	1
Paroxetine	Pimozide	0.091	Inf	Major	1 (1/0)	The serum concentration of Pimozide can be increased when it is combined with Paroxetine.	#B32020	0.454555785358758	1
Lovastatin	Ketoconazole	1	Inf	Major	1 (1/0)	The serum concentration of Lovastatin can be increased when it is combined with Ketoconazole.	#B32020	0.454555785358758	1
Diazepam	Josamycin	0.176	Inf	None	4 (4/0)		#B32020	1.81822314143503	1
Tacrolimus	Clarithromycin	1	Inf	Major	3 (3/0)	The serum concentration of Tacrolimus can be increased when it is combined with Clarithromycin.	#B32020	1.36366735607627	1
Rivastigmine	Clomipramine	0.335	-1.489	Moderate	5 (3/2)		#ABCBE2	2.27277892679379	1
Epinephrine	Carvedilol	0.11	Inf	Major	2 (2/0)	Epinephrine may increase the atrioventricular blocking (AV block) activities of Carvedilol.	#B32020	0.909111570717516	1
Donepezil	Glycopyrronium	0.394	-4.468	None	9 (3/6)	The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Donepezil.	#73A0C9	4.09100206822882	1
Pioglitazone	Gemfibrozil	0.417	Inf	Major	1 (1/0)	The metabolism of Pioglitazone can be decreased when combined with Gemfibrozil.	#B32020	0.454555785358758	1
Galantamine	Glycopyrronium	0.096	-1.117	None	3 (2/1)	The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Galantamine.	#B2D0E5	1.36366735607627	1
Moxifloxacin	Sotalol	0.103	-2.234	Major	4 (2/2)	Moxifloxacin may increase the QTc-prolonging activities of Sotalol.	#9DC0DC	1.81822314143503	1
Captopril	Lithium cation	1	Inf	Moderate	1 (1/0)	The serum concentration of Lithium can be increased when it is combined with Captopril.	#B32020	0.454555785358758	1
Tacrolimus	Nifedipine	0.373	-1.117	Moderate	3 (2/1)	The serum concentration of Tacrolimus can be increased when it is combined with Nifedipine.	#B2D0E5	1.36366735607627	1
Clemastine	Donepezil	0.038	Inf	Moderate	1 (1/0)	The metabolism of Donepezil can be decreased when combined with Clemastine.	#B32020	0.454555785358758	1
Cyclosporine	Naproxen	0.016	Inf	Moderate	1 (1/0)	Naproxen may increase the nephrotoxic activities of Cyclosporine.	#B32020	0.454555785358758	1
Ticlopidine	Acetylsalicylic acid	0.24	1.194	Moderate	11 (8/3)	The risk or severity of adverse effects can be increased when Ticlopidine is combined with Acetylsalicylic acid.	#F7B9B9	5.00011363894634	1
Griseofulvin	Acetylsalicylic acid	0.037	Inf	Minor	2 (2/0)		#B32020	0.909111570717516	1
Cyclosporine	Diltiazem	0.083	Inf	Moderate	1 (1/0)	The metabolism of Cyclosporine can be decreased when combined with Diltiazem.	#B32020	0.454555785358758	1
Bisoprolol	Epinephrine	0.108	Inf	Moderate	4 (4/0)	Epinephrine may increase the atrioventricular blocking (AV block) activities of Bisoprolol.	#B32020	1.81822314143503	1
Fluconazole	Fluvastatin	0.39	-2.234	Moderate	6 (3/3)	The serum concentration of Fluvastatin can be increased when it is combined with Fluconazole.	#9DC0DC	2.72733471215255	1
Moxifloxacin	Josamycin	0.833	Inf	None	3 (3/0)		#B32020	1.36366735607627	1
Primidone	Methylprednisolone	0.097	-1.117	Moderate	3 (2/1)	The serum concentration of Methylprednisolone can be decreased when it is combined with Primidone.	#B2D0E5	1.36366735607627	1
Warfarin	Etoricoxib	0.063	1.343	None	4 (3/1)	Etoricoxib may increase the anticoagulant activities of Warfarin.	#F6B6B6	1.81822314143503	1
Disulfiram	Acenocoumarol	0.066	-2.234	None	2 (1/1)	The serum concentration of Acenocoumarol can be increased when it is combined with Disulfiram.	#9DC0DC	0.909111570717516	1
Ergotamine	Clarithromycin	0.528	Inf	Major	2 (2/0)	The serum concentration of Ergotamine can be increased when it is combined with Clarithromycin.	#B32020	0.909111570717516	1
Warfarin	Fluvastatin	0.231	-4.468	Minor	6 (2/4)	The metabolism of Warfarin can be decreased when combined with Fluvastatin.	#73A0C9	2.72733471215255	1
Erythromycin	Warfarin	0.076	-1.489	Major	5 (3/2)	The serum concentration of Warfarin can be increased when it is combined with Erythromycin.	#ABCBE2	2.27277892679379	1
Diltiazem	Cilostazol	0.218	-5.212	Major	10 (3/7)	The serum concentration of Cilostazol can be increased when it is combined with Diltiazem.	#6395C3	4.54555785358758	1
Ceftriaxone	Acenocoumarol	0.093	-2.513	None	17 (8/9)	Ceftriaxone may increase the anticoagulant activities of Acenocoumarol.	#97BCD9	7.72744835109889	1
Haloperidol	Ketoconazole	0.255	Inf	Major	3 (3/0)	The metabolism of Haloperidol can be decreased when combined with Ketoconazole.	#B32020	1.36366735607627	1
Fluconazole	Cilostazol	0.193	-3.351	Major	5 (2/3)	The serum concentration of Cilostazol can be increased when it is combined with Fluconazole.	#88B0D3	2.27277892679379	1
Repaglinide	Glucosamine	0.224	1.119	None	7 (5/2)		#F8BABA	3.18189049751131	1
Fluoxetine	Almotriptan	0.111	-2.234	Major	2 (1/1)	The metabolism of Almotriptan can be decreased when combined with Fluoxetine.	#9DC0DC	0.909111570717516	1
Galantamine	Ketoconazole	0.067	Inf	Moderate	1 (1/0)	The metabolism of Galantamine can be decreased when combined with Ketoconazole.	#B32020	0.454555785358758	1
Ranitidine	Ketoconazole	0.357	-1.117	Moderate	3 (2/1)	The serum concentration of Ketoconazole can be decreased when it is combined with Ranitidine.	#B2D0E5	1.36366735607627	1
Digoxin	Bumetanide	0.672	Inf	Moderate	2 (2/0)	The risk or severity of adverse effects can be increased when Bumetanide is combined with Digoxin.	#B32020	0.909111570717516	1
Dextromethorphan	Selegiline	0.265	-2.234	Major	4 (2/2)	Selegiline may increase the serotonergic activities of Dextromethorphan.	#9DC0DC	1.81822314143503	1
Trospium	Rivastigmine	0.212	-5.585	Moderate	7 (2/5)	The therapeutic efficacy of Trospium can be decreased when used in combination with Rivastigmine.	#5D90C0	3.18189049751131	1
Tizanidine	Donepezil	0.057	Inf	Moderate	2 (2/0)	Tizanidine may increase the bradycardic activities of Donepezil.	#B32020	0.909111570717516	1
Ofloxacin	Acenocoumarol	0.118	-3.351	None	10 (4/6)		#88B0D3	4.54555785358758	1
Metoprolol	Indomethacin	0.5	Inf	Moderate	1 (1/0)	Indomethacin may decrease the antihypertensive activities of Metoprolol.	#B32020	0.454555785358758	1
Azathioprine	Acenocoumarol	0.314	-3.723	None	8 (3/5)	Azathioprine may decrease the anticoagulant activities of Acenocoumarol.	#80ABCF	3.63644628287007	1
Ketoconazole	Budesonide	0.241	1.343	Major	4 (3/1)	The serum concentration of Budesonide can be increased when it is combined with Ketoconazole.	#F6B6B6	1.81822314143503	1
Fluconazole	Tacrolimus	0.227	-3.351	Major	5 (2/3)	The serum concentration of Tacrolimus can be increased when it is combined with Fluconazole.	#88B0D3	2.27277892679379	1
Alendronic acid	Ketoprofen	0.333	Inf	Moderate	2 (2/0)	The risk or severity of adverse effects can be increased when Ketoprofen is combined with Alendronic acid.	#B32020	0.909111570717516	1
Rifampicin	Acenocoumarol	0.248	-2.234	None	8 (4/4)	The metabolism of Acenocoumarol can be increased when combined with Rifampicin.	#9DC0DC	3.63644628287007	1
Chlorpropamide	Acetylsalicylic acid	0.216	-2.234	None	4 (2/2)	Acetylsalicylic acid may increase the hypoglycemic activities of Chlorpropamide.	#9DC0DC	1.81822314143503	1
Flurbiprofen	Acenocoumarol	0.11	-2.234	None	4 (2/2)	Flurbiprofen may increase the anticoagulant activities of Acenocoumarol.	#9DC0DC	1.81822314143503	1
Trospium	Tiotropium	0.347	-1.117	Moderate	3 (2/1)	Trospium may increase the anticholinergic activities of Tiotropium.	#B2D0E5	1.36366735607627	1
Atorvastatin	Bezafibrate	0.242	1.343	None	4 (3/1)	Bezafibrate may increase the myopathic rhabdomyolysis activities of Atorvastatin.	#F6B6B6	1.81822314143503	1
Rifampicin	Clarithromycin	0.802	-4.468	Moderate	6 (2/4)	The serum concentration of the active metabolites of Clarithromycin can be increased when Clarithromycin is used in combination with Rifampicin.	#73A0C9	2.72733471215255	1
Codeine	Cimetidine	0.091	Inf	Moderate	1 (1/0)	The therapeutic efficacy of Codeine can be decreased when used in combination with Cimetidine.	#B32020	0.454555785358758	1
Fludrocortisone	Acenocoumarol	0.353	-4.468	None	6 (2/4)		#73A0C9	2.72733471215255	1
Prednisone	Rifampicin	0.476	-1.675	Moderate	7 (4/3)	The serum concentration of Prednisone can be decreased when it is combined with Rifampicin.	#A8C8E1	3.18189049751131	1
Cyclobenzaprine	Rivastigmine	0.261	-1.117	Moderate	3 (2/1)		#B2D0E5	1.36366735607627	1
Tobramycin	Cefonicid	0.25	Inf	Moderate	1 (1/0)		#B32020	0.454555785358758	1
Midazolam	Josamycin	0.083	Inf	None	1 (1/0)	The serum concentration of Midazolam can be increased when it is combined with Josamycin.	#B32020	0.454555785358758	1
Cyclosporine	Ibuprofen	0.099	Inf	Moderate	2 (2/0)	Ibuprofen may increase the nephrotoxic activities of Cyclosporine.	#B32020	0.909111570717516	1
Theophylline	Terbinafine	0.022	Inf	Moderate	1 (1/0)	The metabolism of Theophylline can be decreased when combined with Terbinafine.	#B32020	0.454555785358758	1
Cilostazol	Itraconazole	0.072	-2.234	Major	2 (1/1)	The serum concentration of Cilostazol can be increased when it is combined with Itraconazole.	#9DC0DC	0.909111570717516	1
Theophylline	Verapamil	0.464	-3.351	Moderate	5 (2/3)	The metabolism of Theophylline can be decreased when combined with Verapamil.	#88B0D3	2.27277892679379	1
Haloperidol	Glycopyrronium	0.239	-5.808	Moderate	18 (5/13)	The serum concentration of Haloperidol can be decreased when it is combined with Glycopyrronium.	#598DBE	8.18200413645765	1
Pregabalin	Pioglitazone	0.315	-3.351	Moderate	5 (2/3)	The risk or severity of heart failure can be increased when Pregabalin is combined with Pioglitazone.	#88B0D3	2.27277892679379	1
Galantamine	Biperiden	0.084	Inf	Moderate	2 (2/0)	The therapeutic efficacy of Biperiden can be decreased when used in combination with Galantamine.	#B32020	0.909111570717516	1
Itraconazole	Clarithromycin	0.471	-1.117	Moderate	6 (4/2)	The metabolism of Clarithromycin can be decreased when combined with Itraconazole.	#B2D0E5	2.72733471215255	1
Losartan	Lithium cation	0.204	-2.234	Moderate	4 (2/2)	The serum concentration of Lithium can be increased when it is combined with Losartan.	#9DC0DC	1.81822314143503	1
Minocycline	Iron	0.142	-1.117	Moderate	3 (2/1)	Minocycline can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B2D0E5	1.36366735607627	1
Methylprednisolone	Rifampicin	0.426	-1.117	Moderate	3 (2/1)	The serum concentration of Methylprednisolone can be decreased when it is combined with Rifampicin.	#B2D0E5	1.36366735607627	1
Repaglinide	Josamycin	0.065	-1.117	None	3 (2/1)	The serum concentration of Repaglinide can be increased when it is combined with Josamycin.	#B2D0E5	1.36366735607627	1
Dihydroergotamine	Carvedilol	0.225	Inf	Moderate	2 (2/0)	Dihydroergotamine may increase the atrioventricular blocking (AV block) activities of Carvedilol.	#B32020	0.909111570717516	1
Fluorouracil	Warfarin	0.041	-2.234	Major	2 (1/1)	The serum concentration of Warfarin can be increased when it is combined with Fluorouracil.	#9DC0DC	0.909111570717516	1
Amitriptyline	Ketoconazole	0.5	Inf	Moderate	1 (1/0)	The metabolism of Amitriptyline can be decreased when combined with Ketoconazole.	#B32020	0.454555785358758	1
Donepezil	Cyclobenzaprine	0.114	-1.117	Moderate	3 (2/1)		#B2D0E5	1.36366735607627	1
Lovastatin	Rifampicin	0.118	Inf	Major	1 (1/0)	The metabolism of Lovastatin can be increased when combined with Rifampicin.	#B32020	0.454555785358758	1
Duloxetine	Flecainide	0.131	-3.351	Moderate	5 (2/3)	The metabolism of Flecainide can be decreased when combined with Duloxetine.	#88B0D3	2.27277892679379	1
Indomethacin	Warfarin	0.073	-1.117	Major	3 (2/1)	Indomethacin may increase the anticoagulant activities of Warfarin.	#B2D0E5	1.36366735607627	1
Verapamil	Rifampicin	0.375	Inf	Moderate	1 (1/0)	The metabolism of Verapamil can be increased when combined with Rifampicin.	#B32020	0.454555785358758	1
Bisoprolol	Chlorpropamide	0.103	Inf	Moderate	1 (1/0)	Bisoprolol may increase the hypoglycemic activities of Chlorpropamide.	#B32020	0.454555785358758	1
Primidone	Nifedipine	0.444	Inf	Major	1 (1/0)	The serum concentration of Nifedipine can be decreased when it is combined with Primidone.	#B32020	0.454555785358758	1
Cimetidine	Fentanyl	0.111	Inf	Moderate	1 (1/0)		#B32020	0.454555785358758	1
Cyclosporine	Atorvastatin	0.385	Inf	Major	1 (1/0)	The serum concentration of Atorvastatin can be increased when it is combined with Cyclosporine.	#B32020	0.454555785358758	1
Propranolol	Epinephrine	0.091	Inf	Major	1 (1/0)	Epinephrine may increase the atrioventricular blocking (AV block) activities of Propranolol.	#B32020	0.454555785358758	1
Erythromycin	Midazolam	0.066	-2.234	Moderate	4 (2/2)	The serum concentration of Midazolam can be increased when it is combined with Erythromycin.	#9DC0DC	1.81822314143503	1
Prednisone	Estriol	0.181	Inf	None	3 (3/0)	The serum concentration of Prednisone can be increased when it is combined with Estriol.	#B32020	1.36366735607627	1
Fluconazole	Imipramine	0.136	-2.234	Moderate	2 (1/1)	The metabolism of Imipramine can be decreased when combined with Fluconazole.	#9DC0DC	0.909111570717516	1
Haloperidol	Rifampicin	0.287	-1.489	Major	5 (3/2)	The metabolism of Haloperidol can be increased when combined with Rifampicin.	#ABCBE2	2.27277892679379	1
Alprazolam	Cimetidine	0.333	Inf	Moderate	1 (1/0)		#B32020	0.454555785358758	1
Trihexyphenidyl	Rivastigmine	0.125	Inf	Moderate	1 (1/0)	The therapeutic efficacy of Trihexyphenidyl can be decreased when used in combination with Rivastigmine.	#B32020	0.454555785358758	1
Fluconazole	Celecoxib	0.242	1.791	Moderate	5 (4/1)	The metabolism of Celecoxib can be decreased when combined with Fluconazole.	#F2AEAE	2.27277892679379	1
Lovastatin	Bezafibrate	0.226	-2.234	None	2 (1/1)	Bezafibrate may increase the myopathic rhabdomyolysis activities of Lovastatin.	#9DC0DC	0.909111570717516	1
Theophylline	Propafenone	0.216	-4.468	Moderate	3 (1/2)	The serum concentration of Theophylline can be increased when it is combined with Propafenone.	#73A0C9	1.36366735607627	1
Digoxin	Prazosin	0.314	-4.468	None	3 (1/2)		#73A0C9	1.36366735607627	1
Hydrocortisone	Primidone	0.11	-2.234	Moderate	2 (1/1)	The serum concentration of Hydrocortisone can be decreased when it is combined with Primidone.	#9DC0DC	0.909111570717516	1
Cyclosporine	Metoclopramide	0.5	Inf	Moderate	1 (1/0)	Metoclopramide can cause an increase in the absorption of Cyclosporine resulting in an increased serum concentration and potentially a worsening of adverse effects.	#B32020	0.454555785358758	1
Tizanidine	Lisinopril	0.306	-1.117	Major	3 (2/1)	Tizanidine may increase the hypotensive activities of Lisinopril.	#B2D0E5	1.36366735607627	1
Ofloxacin	Iron	0.722	-1.117	None	3 (2/1)		#B2D0E5	1.36366735607627	1
Nortriptyline	Donepezil	0.611	Inf	Moderate	1 (1/0)		#B32020	0.454555785358758	1
Sulindac	Furosemide	0.05	Inf	Moderate	1 (1/0)	The therapeutic efficacy of Furosemide can be decreased when used in combination with Sulindac.	#B32020	0.454555785358758	1
Ziprasidone	Amiodarone	0.556	Inf	Major	1 (1/0)	The risk or severity of QTc prolongation can be increased when Ziprasidone is combined with Amiodarone.	#B32020	0.454555785358758	1
Erythromycin	Felodipine	0.061	-6.702	Moderate	4 (1/3)	The metabolism of Felodipine can be decreased when combined with Erythromycin.	#4880B7	1.81822314143503	1
Galantamine	Tizanidine	0.5	Inf	Moderate	1 (1/0)	Galantamine may increase the bradycardic activities of Tizanidine.	#B32020	0.454555785358758	1
Fluoxetine	Ergotamine	0.537	-2.234	Major	2 (1/1)	The risk or severity of adverse effects can be increased when Ergotamine is combined with Fluoxetine.	#9DC0DC	0.909111570717516	1
Imipramine	Rivastigmine	0.5	Inf	Moderate	1 (1/0)		#B32020	0.454555785358758	1
Ibuprofen	Nadolol	0.121	Inf	Moderate	2 (2/0)	Ibuprofen may decrease the antihypertensive activities of Nadolol.	#B32020	0.909111570717516	1
Tetracycline	Acenocoumarol	0.048	Inf	None	1 (1/0)		#B32020	0.454555785358758	1
Citalopram	Pimozide	0.035	Inf	Major	1 (1/0)	The risk or severity of QTc prolongation can be increased when Citalopram is combined with Pimozide.	#B32020	0.454555785358758	1
Erythromycin	Cilostazol	0.279	-2.234	Major	2 (1/1)	The serum concentration of Cilostazol can be increased when it is combined with Erythromycin.	#9DC0DC	0.909111570717516	1
Methotrexate	Sulfamethoxazole	0.096	Inf	Moderate	2 (2/0)	The risk or severity of adverse effects can be increased when Sulfamethoxazole is combined with Methotrexate.	#B32020	0.909111570717516	1
Torasemide	Tobramycin	0.02	-2.234	Major	4 (2/2)	The serum concentration of Tobramycin can be increased when it is combined with Torasemide.	#9DC0DC	1.81822314143503	1
Ranolazine	Digoxin	0.165	-1.489	Moderate	5 (3/2)	The serum concentration of Digoxin can be increased when it is combined with Ranolazine.	#ABCBE2	2.27277892679379	1
Salbutamol	Oxprenolol	0.111	Inf	None	1 (1/0)	Oxprenolol may decrease the bronchodilatory activities of Salbutamol.	#B32020	0.454555785358758	1
Trazodone	Ketoconazole	0.047	Inf	Moderate	2 (2/0)	The metabolism of Trazodone can be decreased when combined with Ketoconazole.	#B32020	0.909111570717516	1
Trimethoprim	Methotrexate	0.096	Inf	Major	2 (2/0)	The risk or severity of adverse effects can be increased when Trimethoprim is combined with Methotrexate.	#B32020	0.909111570717516	1
Metformin	Cimetidine	0.206	Inf	Moderate	1 (1/0)	The serum concentration of Metformin can be increased when it is combined with Cimetidine.	#B32020	0.454555785358758	1
Tacrolimus	Metronidazole	0.333	Inf	Moderate	1 (1/0)		#B32020	0.454555785358758	1
Diazepam	Rifampicin	0.486	-2.234	Minor	4 (2/2)	The metabolism of Diazepam can be increased when combined with Rifampicin.	#9DC0DC	1.81822314143503	1
Warfarin	Terbinafine	0.088	Inf	Moderate	1 (1/0)		#B32020	0.454555785358758	1
Phenytoin	Itraconazole	0.562	-2.234	Moderate	2 (1/1)	The serum concentration of Itraconazole can be decreased when it is combined with Phenytoin.	#9DC0DC	0.909111570717516	1
Prazosin	Bisoprolol	0.115	Inf	Moderate	1 (1/0)	Bisoprolol may increase the orthostatic hypotensive activities of Prazosin.	#B32020	0.454555785358758	1
Rabeprazole	Itraconazole	0.064	-1.117	Moderate	3 (2/1)	The serum concentration of Itraconazole can be decreased when it is combined with Rabeprazole.	#B2D0E5	1.36366735607627	1
Lovastatin	Tacrolimus	0.026	Inf	Moderate	1 (1/0)	The serum concentration of Lovastatin can be increased when it is combined with Tacrolimus.	#B32020	0.454555785358758	1
Hydrocortisone	Rifampicin	0.17	-4.468	Moderate	3 (1/2)	The serum concentration of Hydrocortisone can be decreased when it is combined with Rifampicin.	#73A0C9	1.36366735607627	1
Dextromethorphan	Terbinafine	0.483	-1.117	Major	3 (2/1)	The metabolism of Dextromethorphan can be decreased when combined with Terbinafine.	#B2D0E5	1.36366735607627	1
Digoxin	Minocycline	0.127	Inf	Moderate	2 (2/0)		#B32020	0.909111570717516	1
Glyburide	Rifampicin	0.228	-6.702	Moderate	4 (1/3)	The serum concentration of Glyburide can be decreased when it is combined with Rifampicin.	#4880B7	1.81822314143503	1
Fluconazole	Carbamazepine	0.338	-3.351	Moderate	5 (2/3)	The serum concentration of Carbamazepine can be increased when it is combined with Fluconazole.	#88B0D3	2.27277892679379	1
Indomethacin	Propranolol	0.177	-3.351	Moderate	5 (2/3)	Indomethacin may decrease the antihypertensive activities of Propranolol.	#88B0D3	2.27277892679379	1
Triazolam	Clarithromycin	0.082	-4.468	Moderate	3 (1/2)	The serum concentration of Triazolam can be increased when it is combined with Clarithromycin.	#73A0C9	1.36366735607627	1
Digoxin	Telithromycin	0.09	-2.234	Moderate	2 (1/1)	The metabolism of Digoxin can be decreased when combined with Telithromycin.	#9DC0DC	0.909111570717516	1
Erythromycin	Lovastatin	0.032	-3.351	Major	5 (2/3)	The serum concentration of Lovastatin can be increased when it is combined with Erythromycin.	#88B0D3	2.27277892679379	1
Sucralfate	Itraconazole	0.4	Inf	None	1 (1/0)	Sucralfate can cause a decrease in the absorption of Itraconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B32020	0.454555785358758	1
Ketoconazole	Acenocoumarol	0.05	-1.117	None	3 (2/1)	The serum concentration of Acenocoumarol can be increased when it is combined with Ketoconazole.	#B2D0E5	1.36366735607627	1
Ergotamine	Isosorbide mononitrate	0.521	-2.234	Moderate	2 (1/1)		#9DC0DC	0.909111570717516	1
Methylprednisolone	Itraconazole	0.655	-2.978	Major	7 (3/4)	The serum concentration of Methylprednisolone can be increased when it is combined with Itraconazole.	#90B6D6	3.18189049751131	1
Atenolol	Piroxicam	0.125	-4.468	Moderate	3 (1/2)	Piroxicam may decrease the antihypertensive activities of Atenolol.	#73A0C9	1.36366735607627	1
Trospium	Tolterodine	0.389	-6.702	Moderate	4 (1/3)	The risk or severity of adverse effects can be increased when Trospium is combined with Tolterodine.	#4880B7	1.81822314143503	1
Diclofenac	Lithium cation	0.625	-2.234	Moderate	2 (1/1)	The serum concentration of Lithium can be increased when it is combined with Diclofenac.	#9DC0DC	0.909111570717516	1
Atenolol	Epinephrine	0.081	Inf	Moderate	1 (1/0)	Epinephrine may increase the atrioventricular blocking (AV block) activities of Atenolol.	#B32020	0.454555785358758	1
Atenolol	Ampicillin	0.048	Inf	Moderate	1 (1/0)	The bioavailability of Atenolol can be decreased when combined with Ampicillin.	#B32020	0.454555785358758	1
Carbamazepine	Itraconazole	0.062	Inf	Moderate	1 (1/0)	The serum concentration of Itraconazole can be decreased when it is combined with Carbamazepine.	#B32020	0.454555785358758	1
Ampicillin	Acenocoumarol	0.034	-3.351	None	5 (2/3)	Ampicillin may increase the anticoagulant activities of Acenocoumarol.	#88B0D3	2.27277892679379	1
Fluconazole	Ranolazine	0.088	-2.234	Major	2 (1/1)	The serum concentration of Ranolazine can be increased when it is combined with Fluconazole.	#9DC0DC	0.909111570717516	1
Piroxicam	Carvedilol	0.333	Inf	Moderate	1 (1/0)	Piroxicam may decrease the antihypertensive activities of Carvedilol.	#B32020	0.454555785358758	1
Carbamazepine	Midazolam	0.125	Inf	Moderate	1 (1/0)	The metabolism of Midazolam can be increased when combined with Carbamazepine.	#B32020	0.454555785358758	1
Phenytoin	Warfarin	0.103	-2.234	Moderate	2 (1/1)	Phenytoin may increase the anticoagulant activities of Warfarin.	#9DC0DC	0.909111570717516	1
Tizanidine	Captopril	0.03	-2.234	Major	2 (1/1)	The risk or severity of hypotension can be increased when Tizanidine is combined with Captopril.	#9DC0DC	0.909111570717516	1
Repaglinide	Rifampicin	0.115	-8.935	Moderate	5 (1/4)	The serum concentration of Repaglinide can be decreased when it is combined with Rifampicin.	#1E61A5	2.27277892679379	1
Doxycycline	Insulin aspart	0.187	-2.234	Moderate	2 (1/1)		#9DC0DC	0.909111570717516	1
Midazolam	Itraconazole	0.016	Inf	Major	1 (1/0)	The serum concentration of Midazolam can be increased when it is combined with Itraconazole.	#B32020	0.454555785358758	1
Sotalol	Formoterol	0.071	Inf	Major	1 (1/0)	Formoterol may increase the QTc-prolonging activities of Sotalol.	#B32020	0.454555785358758	1
Colestipol	Digoxin	0.201	-2.234	Moderate	2 (1/1)	Colestipol can cause a decrease in the absorption of Digoxin resulting in a reduced serum concentration and potentially a decrease in efficacy.	#9DC0DC	0.909111570717516	1
Verapamil	Eplerenone	0.485	-4.468	Moderate	3 (1/2)	The serum concentration of Eplerenone can be increased when it is combined with Verapamil.	#73A0C9	1.36366735607627	1
Warfarin	Ceftriaxone	1	Inf	Moderate	1 (1/0)	Ceftriaxone may increase the anticoagulant activities of Warfarin.	#B32020	0.454555785358758	1
Duloxetine	Propafenone	0.583	-2.234	Moderate	2 (1/1)	The serum concentration of Duloxetine can be increased when it is combined with Propafenone.	#9DC0DC	0.909111570717516	1
Terbutaline	Clomipramine	0.048	Inf	Moderate	1 (1/0)	The risk or severity of adverse effects can be increased when Clomipramine is combined with Terbutaline.	#B32020	0.454555785358758	1
Donepezil	Maprotiline	0.086	-2.234	Moderate	2 (1/1)		#9DC0DC	0.909111570717516	1
Haloperidol	Lithium cation	0.733	-2.234	Major	2 (1/1)	Lithium may increase the neurotoxic activities of Haloperidol.	#9DC0DC	0.909111570717516	1
Theophylline	Acyclovir	0.029	Inf	Minor	1 (1/0)		#B32020	0.454555785358758	1
Fenofibrate	Ursodeoxycholic acid	0.015	Inf	None	1 (1/0)	The therapeutic efficacy of Ursodeoxycholic acid can be decreased when used in combination with Fenofibrate.	#B32020	0.454555785358758	1
Almotriptan	Sertraline	0.048	-2.234	Major	2 (1/1)	The risk or severity of adverse effects can be increased when Almotriptan is combined with Sertraline.	#9DC0DC	0.909111570717516	1
Morphine	Rifampicin	0.375	-2.234	Moderate	2 (1/1)	The serum concentration of Morphine can be decreased when it is combined with Rifampicin.	#9DC0DC	0.909111570717516	1
Medroxyprogesterone acetate	Acenocoumarol	0.213	-2.234	None	2 (1/1)	Medroxyprogesterone acetate may decrease the anticoagulant activities of Acenocoumarol.	#9DC0DC	0.909111570717516	1
Cyclosporine	Ciprofloxacin	0.154	Inf	Moderate	1 (1/0)		#B32020	0.454555785358758	1
Simvastatin	Telithromycin	0.167	Inf	Major	1 (1/0)	The serum concentration of Simvastatin can be increased when it is combined with Telithromycin.	#B32020	0.454555785358758	1
Salbutamol	Nadolol	0.043	-2.234	Major	2 (1/1)		#9DC0DC	0.909111570717516	1
Metoprolol	Escitalopram	0.47	-2.234	Minor	2 (1/1)	The serum concentration of Metoprolol can be increased when it is combined with Escitalopram.	#9DC0DC	0.909111570717516	1
Amikacin	Cefuroxime	0.586	-4.468	Moderate	3 (1/2)		#73A0C9	1.36366735607627	1
Amitriptyline	Pseudoephedrine	0.05	Inf	None	1 (1/0)	Amitriptyline may decrease the antihypertensive activities of Pseudoephedrine.	#B32020	0.454555785358758	1
Rifampicin	Gliclazide	0.153	-2.234	None	2 (1/1)	The serum concentration of Gliclazide can be decreased when it is combined with Rifampicin.	#9DC0DC	0.909111570717516	1
Dihydroergotamine	Bisoprolol	0.092	-2.234	Moderate	4 (2/2)	Dihydroergotamine may increase the atrioventricular blocking (AV block) activities of Bisoprolol.	#9DC0DC	1.81822314143503	1
Piroxicam	Alendronic acid	0.045	Inf	None	1 (1/0)	The risk or severity of adverse effects can be increased when Piroxicam is combined with Alendronic acid.	#B32020	0.454555785358758	1
Erythromycin	Colchicine	1	Inf	Major	1 (1/0)	The serum concentration of Colchicine can be increased when it is combined with Erythromycin.	#B32020	0.454555785358758	1
Ranolazine	Clarithromycin	1	Inf	Major	1 (1/0)	The serum concentration of Ranolazine can be increased when it is combined with Clarithromycin.	#B32020	0.454555785358758	1
Carbamazepine	Verapamil	0.311	-2.234	Major	2 (1/1)	The serum concentration of Carbamazepine can be increased when it is combined with Verapamil.	#9DC0DC	0.909111570717516	1
Chlorpromazine	Donepezil	0.31	-6.702	Moderate	4 (1/3)	The metabolism of Donepezil can be decreased when combined with Chlorpromazine.	#4880B7	1.81822314143503	1
Verapamil	Colchicine	0.097	-6.702	Major	4 (1/3)	The serum concentration of Colchicine can be increased when it is combined with Verapamil.	#4880B7	1.81822314143503	1
Verapamil	Midazolam	0.187	-2.234	Moderate	2 (1/1)	The metabolism of Midazolam can be decreased when combined with Verapamil.	#9DC0DC	0.909111570717516	1
Methotrexate	Cloxacillin	0.133	Inf	Major	1 (1/0)	The serum concentration of Methotrexate can be increased when it is combined with Cloxacillin.	#B32020	0.454555785358758	1
Leflunomide	Acenocoumarol	0.286	-4.468	None	3 (1/2)	Leflunomide may increase the anticoagulant activities of Acenocoumarol.	#73A0C9	1.36366735607627	1
Bumetanide	Ibuprofen	0.03	-2.234	Moderate	2 (1/1)	The therapeutic efficacy of Bumetanide can be decreased when used in combination with Ibuprofen.	#9DC0DC	0.909111570717516	1
Doxycycline	Cloxacillin	1	Inf	Moderate	1 (1/0)	The therapeutic efficacy of Cloxacillin can be decreased when used in combination with Doxycycline.	#B32020	0.454555785358758	1
Celecoxib	Warfarin	0.037	-4.468	Moderate	3 (1/2)	Celecoxib may increase the anticoagulant activities of Warfarin.	#73A0C9	1.36366735607627	1
Piroxicam	Bisoprolol	0.317	-2.234	Moderate	2 (1/1)	Piroxicam may decrease the antihypertensive activities of Bisoprolol.	#9DC0DC	0.909111570717516	1
Doxycycline	Iron	0.4	-4.468	Moderate	3 (1/2)	Doxycycline can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy.	#73A0C9	1.36366735607627	1
Clarithromycin	Colchicine	0.35	-2.234	Major	2 (1/1)	The serum concentration of Colchicine can be increased when it is combined with Clarithromycin.	#9DC0DC	0.909111570717516	1
Ceftazidime	Amikacin	0.5	-Inf	Moderate	1 (0/1)		#1E61A5	0.454555785358758	1
Dihydroergotamine	Sumatriptan	0.5	-Inf	Major	1 (0/1)	Dihydroergotamine may increase the vasoconstricting activities of Sumatriptan.	#1E61A5	0.454555785358758	1
Lamotrigine	Carbamazepine	0.506	-Inf	Moderate	6 (0/6)	The risk or severity of adverse effects can be increased when Lamotrigine is combined with Carbamazepine.	#1E61A5	2.72733471215255	1
Metoprolol	Prazosin	1	-Inf	Moderate	1 (0/1)	Metoprolol may increase the orthostatic hypotensive activities of Prazosin.	#1E61A5	0.454555785358758	1
Pyridostigmine	Fludrocortisone	0.375	-Inf	Moderate	1 (0/1)	The risk or severity of adverse effects can be increased when Fludrocortisone is combined with Pyridostigmine.	#1E61A5	0.454555785358758	1
Clozapine	Donepezil	0.077	-Inf	Moderate	1 (0/1)	The metabolism of Donepezil can be decreased when combined with Clozapine.	#1E61A5	0.454555785358758	1
Doxycycline	Acitretin	0.143	-Inf	Major	1 (0/1)	The risk or severity of adverse effects can be increased when Doxycycline is combined with Acitretin.	#1E61A5	0.454555785358758	1
Ezetimibe	Cholestyramine	0.136	-Inf	Moderate	3 (0/3)	Cholestyramine can cause a decrease in the absorption of Ezetimibe resulting in a reduced serum concentration and potentially a decrease in efficacy.	#1E61A5	1.36366735607627	1
Methotrexate	Ketoprofen	0.077	-Inf	Major	1 (0/1)	The serum concentration of Methotrexate can be increased when it is combined with Ketoprofen.	#1E61A5	0.454555785358758	1
Epinephrine	Clomipramine	0.25	-Inf	Major	1 (0/1)	Clomipramine may decrease the antihypertensive activities of Epinephrine.	#1E61A5	0.454555785358758	1
Testosterone	Warfarin	0.129	-Inf	Major	2 (0/2)	Testosterone may increase the anticoagulant activities of Warfarin.	#1E61A5	0.909111570717516	1
Cimetidine	Donepezil	0.221	-Inf	Moderate	2 (0/2)	The metabolism of Donepezil can be decreased when combined with Cimetidine.	#1E61A5	0.909111570717516	1
Donepezil	Perphenazine	0.175	-Inf	Moderate	2 (0/2)		#1E61A5	0.909111570717516	1
Perindopril	Lithium cation	0.333	-Inf	Moderate	1 (0/1)	The serum concentration of Lithium can be increased when it is combined with Perindopril.	#1E61A5	0.454555785358758	1
Gliclazide	Nadolol	0.315	-Inf	None	3 (0/3)	Nadolol may increase the hypoglycemic activities of Gliclazide.	#1E61A5	1.36366735607627	1
Salbutamol	Moclobemide	0.192	-Inf	None	2 (0/2)	The risk or severity of adverse effects can be increased when Moclobemide is combined with Salbutamol.	#1E61A5	0.909111570717516	1
Ziprasidone	Carbamazepine	0.5	-Inf	Minor	1 (0/1)	The serum concentration of Ziprasidone can be decreased when it is combined with Carbamazepine.	#1E61A5	0.454555785358758	1
Cyclosporine	Repaglinide	0.229	-Inf	Major	2 (0/2)	The serum concentration of Repaglinide can be increased when it is combined with Cyclosporine.	#1E61A5	0.909111570717516	1
Amitriptyline	Cimetidine	0.077	-Inf	Moderate	1 (0/1)	The metabolism of Amitriptyline can be decreased when combined with Cimetidine.	#1E61A5	0.454555785358758	1
Triamcinolone	Phenobarbital	0.028	-Inf	Moderate	2 (0/2)	The metabolism of Triamcinolone can be increased when combined with Phenobarbital.	#1E61A5	0.909111570717516	1
Citalopram	Clozapine	0.167	-Inf	Major	1 (0/1)	The serum concentration of Clozapine can be increased when it is combined with Citalopram.	#1E61A5	0.454555785358758	1
Bromocriptine	Methotrimeprazine	0.5	-Inf	Moderate	1 (0/1)	The therapeutic efficacy of Methotrimeprazine can be decreased when used in combination with Bromocriptine.	#1E61A5	0.454555785358758	1
Clodronic acid	Iron	0.185	-Inf	None	1 (0/1)		#1E61A5	0.454555785358758	1
Lovastatin	Danazol	0.333	-Inf	Major	1 (0/1)	The risk or severity of myopathy and rhabdomyolysis can be increased when Danazol is combined with Lovastatin.	#1E61A5	0.454555785358758	1
Oxcarbazepine	Felodipine	1	-Inf	Moderate	1 (0/1)		#1E61A5	0.454555785358758	1
Flutamide	Acenocoumarol	0.373	-Inf	None	14 (0/14)		#1E61A5	6.36378099502261	1
Dihydroergotamine	Itraconazole	0.143	-Inf	Major	1 (0/1)	The serum concentration of Dihydroergotamine can be increased when it is combined with Itraconazole.	#1E61A5	0.454555785358758	1
Ketoconazole	Cilostazol	0.032	-Inf	Major	1 (0/1)	The serum concentration of Cilostazol can be increased when it is combined with Ketoconazole.	#1E61A5	0.454555785358758	1
Tacrolimus	Rifampicin	0.167	-Inf	Major	1 (0/1)	The serum concentration of Tacrolimus can be decreased when it is combined with Rifampicin.	#1E61A5	0.454555785358758	1
Erythromycin	Sotalol	0.022	-Inf	Major	1 (0/1)	Erythromycin may increase the QTc-prolonging activities of Sotalol.	#1E61A5	0.454555785358758	1
Tenoxicam	Alendronic acid	0.769	-Inf	None	1 (0/1)	The risk or severity of adverse effects can be increased when Tenoxicam is combined with Alendronic acid.	#1E61A5	0.454555785358758	1
Trospium	Biperiden	0.25	-Inf	Moderate	1 (0/1)	The risk or severity of adverse effects can be increased when Biperiden is combined with Trospium.	#1E61A5	0.454555785358758	1
Rivastigmine	Doxepin	0.235	-Inf	Moderate	1 (0/1)		#1E61A5	0.454555785358758	1
Alfuzosin	Itraconazole	0.043	-Inf	Major	4 (0/4)	The serum concentration of Alfuzosin can be increased when it is combined with Itraconazole.	#1E61A5	1.81822314143503	1
Ticlopidine	Phenytoin	0.565	-Inf	Moderate	1 (0/1)	The serum concentration of Phenytoin can be increased when it is combined with Ticlopidine.	#1E61A5	0.454555785358758	1
Metoprolol	Propafenone	0.167	-Inf	Moderate	1 (0/1)	The serum concentration of Metoprolol can be increased when it is combined with Propafenone.	#1E61A5	0.454555785358758	1
Phenytoin	Flurazepam	0.385	-Inf	Moderate	1 (0/1)	The serum concentration of Phenytoin can be increased when it is combined with Flurazepam.	#1E61A5	0.454555785358758	1
Pseudoephedrine	Clomipramine	0.032	-Inf	None	1 (0/1)	Clomipramine may decrease the antihypertensive activities of Pseudoephedrine.	#1E61A5	0.454555785358758	1
Indomethacin	Sotalol	0.071	-Inf	Moderate	1 (0/1)	Indomethacin may decrease the antihypertensive activities of Sotalol.	#1E61A5	0.454555785358758	1
Erythromycin	Rifampicin	0.5	-Inf	Moderate	1 (0/1)	The metabolism of Erythromycin can be increased when combined with Rifampicin.	#1E61A5	0.454555785358758	1
Phenytoin	Theophylline	0.365	-Inf	Moderate	2 (0/2)	The serum concentration of Theophylline can be decreased when it is combined with Phenytoin.	#1E61A5	0.909111570717516	1
Clozapine	Ciprofloxacin	0.125	-Inf	Major	1 (0/1)	Ciprofloxacin may increase the QTc-prolonging activities of Clozapine.	#1E61A5	0.454555785358758	1
Mefenamic acid	Acenocoumarol	0.462	-Inf	None	1 (0/1)	Mefenamic acid may increase the anticoagulant activities of Acenocoumarol.	#1E61A5	0.454555785358758	1
Metoprolol	Glyburide	0.248	-Inf	Moderate	2 (0/2)	Metoprolol may increase the hypoglycemic activities of Glyburide.	#1E61A5	0.909111570717516	1
Erythromycin	Theophylline	0.115	-Inf	Moderate	2 (0/2)	The metabolism of Theophylline can be decreased when combined with Erythromycin.	#1E61A5	0.909111570717516	1
Sotalol	Terbutaline	0.333	-Inf	Major	1 (0/1)	Terbutaline may increase the QTc-prolonging activities of Sotalol.	#1E61A5	0.454555785358758	1
Rifampicin	Etoricoxib	1	-Inf	None	1 (0/1)	The metabolism of Etoricoxib can be increased when combined with Rifampicin.	#1E61A5	0.454555785358758	1
Naproxen	Lithium cation	0.2	-Inf	Major	1 (0/1)	The serum concentration of Lithium can be increased when it is combined with Naproxen.	#1E61A5	0.454555785358758	1
Fentanyl	Ketoconazole	0.153	-Inf	Major	2 (0/2)	The serum concentration of Fentanyl can be increased when it is combined with Ketoconazole.	#1E61A5	0.909111570717516	1
Lovastatin	Josamycin	0.125	-Inf	None	1 (0/1)	The serum concentration of Lovastatin can be increased when it is combined with Josamycin.	#1E61A5	0.454555785358758	1
Tacrolimus	Itraconazole	0.5	-Inf	Major	1 (0/1)	The serum concentration of Tacrolimus can be increased when it is combined with Itraconazole.	#1E61A5	0.454555785358758	1
Warfarin	Rifampicin	0.2	-Inf	Major	1 (0/1)	The metabolism of Warfarin can be increased when combined with Rifampicin.	#1E61A5	0.454555785358758	1
Famotidine	Itraconazole	0.014	-Inf	Moderate	1 (0/1)	The serum concentration of Itraconazole can be decreased when it is combined with Famotidine.	#1E61A5	0.454555785358758	1
Phenytoin	Tacrolimus	0.021	-Inf	Major	1 (0/1)	The serum concentration of Tacrolimus can be decreased when it is combined with Phenytoin.	#1E61A5	0.454555785358758	1
Metoprolol	Verapamil	0.1	-Inf	Major	1 (0/1)	The serum concentration of Metoprolol can be increased when it is combined with Verapamil.	#1E61A5	0.454555785358758	1
Cefoxitin	Acenocoumarol	0.037	-Inf	None	1 (0/1)	Cefoxitin may increase the anticoagulant activities of Acenocoumarol.	#1E61A5	0.454555785358758	1
Nabumetone	Warfarin	0.05	-Inf	Major	1 (0/1)	Nabumetone may increase the anticoagulant activities of Warfarin.	#1E61A5	0.454555785358758	1
Ketoconazole	Clonazepam	0.111	-Inf	None	1 (0/1)	The metabolism of Clonazepam can be decreased when combined with Ketoconazole.	#1E61A5	0.454555785358758	1
Warfarin	Primidone	0.5	-Inf	Major	1 (0/1)	The metabolism of Warfarin can be increased when combined with Primidone.	#1E61A5	0.454555785358758	1
Glimepiride	Rifampicin	0.333	-Inf	Moderate	1 (0/1)	The serum concentration of Glimepiride can be decreased when it is combined with Rifampicin.	#1E61A5	0.454555785358758	1
Ketoconazole	Tolterodine	0.043	-Inf	Moderate	1 (0/1)	The serum concentration of Tolterodine can be increased when it is combined with Ketoconazole.	#1E61A5	0.454555785358758	1
Fluvoxamine	Warfarin	0.357	-Inf	Moderate	1 (0/1)	The metabolism of Warfarin can be decreased when combined with Fluvoxamine.	#1E61A5	0.454555785358758	1
Capecitabine	Acenocoumarol	0.182	-Inf	None	1 (0/1)	The serum concentration of Acenocoumarol can be increased when it is combined with Capecitabine.	#1E61A5	0.454555785358758	1
Phenytoin	Triamcinolone	0.092	-Inf	Moderate	1 (0/1)	The metabolism of Triamcinolone can be increased when combined with Phenytoin.	#1E61A5	0.454555785358758	1
Ketoprofen	Acenocoumarol	0.072	-Inf	None	2 (0/2)	Ketoprofen may increase the anticoagulant activities of Acenocoumarol.	#1E61A5	0.909111570717516	1
Ketoconazole	Solifenacin	0.077	-Inf	Major	1 (0/1)	The metabolism of Solifenacin can be decreased when combined with Ketoconazole.	#1E61A5	0.454555785358758	1
Testosterone	Acenocoumarol	0.285	-Inf	None	2 (0/2)	Testosterone may increase the anticoagulant activities of Acenocoumarol.	#1E61A5	0.909111570717516	1
Cyclosporine	Digoxin	0.024	-Inf	Moderate	1 (0/1)	The serum concentration of Digoxin can be increased when it is combined with Cyclosporine.	#1E61A5	0.454555785358758	1
Dihydroergotamine	Clarithromycin	0.067	-Inf	Major	1 (0/1)	The serum concentration of Dihydroergotamine can be increased when it is combined with Clarithromycin.	#1E61A5	0.454555785358758	1
Rifampicin	Nifedipine	0.25	-Inf	Major	1 (0/1)	The serum concentration of Nifedipine can be decreased when it is combined with Rifampicin.	#1E61A5	0.454555785358758	1
Tetracycline	Amoxicillin	0.6	-Inf	Moderate	2 (0/2)		#1E61A5	0.909111570717516	1
Methylprednisolone	Ketoconazole	0.167	-Inf	Major	1 (0/1)	The serum concentration of Methylprednisolone can be increased when it is combined with Ketoconazole.	#1E61A5	0.454555785358758	1
Doxycycline	Warfarin	0.077	-Inf	Moderate	1 (0/1)	The metabolism of Warfarin can be decreased when combined with Doxycycline.	#1E61A5	0.454555785358758	1
Tenoxicam	Acenocoumarol	0.476	-Inf	None	1 (0/1)	Tenoxicam may increase the anticoagulant activities of Acenocoumarol.	#1E61A5	0.454555785358758	1
Cimetidine	Acenocoumarol	0.333	-Inf	None	1 (0/1)	Cimetidine may increase the anticoagulant activities of Acenocoumarol.	#1E61A5	0.454555785358758	1
Flutamide	Warfarin	0.333	-Inf	Moderate	1 (0/1)		#1E61A5	0.454555785358758	1
Tobramycin	Cefuroxime	0.143	-Inf	Moderate	1 (0/1)		#1E61A5	0.454555785358758	1
Metoprolol	Repaglinide	0.083	-Inf	Moderate	1 (0/1)		#1E61A5	0.454555785358758	1
Piroxicam	Acenocoumarol	0.029	-Inf	None	1 (0/1)	Piroxicam may increase the anticoagulant activities of Acenocoumarol.	#1E61A5	0.454555785358758	1
Spironolactone	Cilazapril	0.316	-Inf	None	1 (0/1)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Cilazapril.	#1E61A5	0.454555785358758	1
Benzylpenicillin	Acenocoumarol	0.333	-Inf	None	1 (0/1)	Benzylpenicillin may increase the anticoagulant activities of Acenocoumarol.	#1E61A5	0.454555785358758	1
Allopurinol	Azathioprine	0.25	-Inf	Major	1 (0/1)	The serum concentration of the active metabolites of Azathioprine can be increased when Azathioprine is used in combination with Allopurinol.	#1E61A5	0.454555785358758	1
